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Developments in the basic sciences during recent decades have made
it possible to perform meaningful scientific investigations concerning
living man. Sufficiently sophisticated tools have been developed and
many of the necessary experiments with inanimate matter and lower life-
forms have been performed. The use of human subjects in any research
program, however, raises questions of ethics and propriety which rarely
arise in most scientific investigations. When the number of such
studies on the Urbana-Champaign campus was quite small, the University
administration did not play a major role in assuring the protection of
human subjects. The academic departments engaged in such work relied
primarily on the professional code of ethics of the individual inves-
tigators involved.
With the increasing possibilities for scientific attention to the
problems of human life in the years following World War II, it became
necessary for the University to formulate more general principles for
the guidance of faculty members engaged in research work with human
subjects. In 1964 an ad hoc committee appointed by the Provost, consist-
ing of F. E. Boys, M.D.; W. H. Davis, LL.M. ; L. G. Humphreys, Ph.D.;
0. S. Walters, M.D.; and F. Sargent, M.D., Chairman, developed such a set
of general principles. These were published in a document entitled Guide
to Experimental Use of Human Subjects . The responsibility for supervision
remained with the department executive officers.
In the past few years, the United States Surgeon General issued
policy and procedure orders and revisions which set special requirements
regarding the use of human subjects in research, and the institutional
review of such use, when activities were undertaken with support from the
Public Health Service. More recently these additional requirements have
been extended to cover work supported by any agency within the U. S.
Department of Health Education and Welfare. Some other sponsoring agencies,
e.g. U. S. Department of Agriculture, have adopted the DHEW regulations as
well.
In 1974 continuing concern for the welfare of human subjects in
biomedical and behavioral research led to the establishment of a Presi-
dential Commission to study the ethical questions concerned and to the
incorporation in the National Research Service Award Act of 1974 (Public
Law 93-348) of a broader requirement for institutional review of
activities involving human subjects.
The basic ethical principles developed in the mid-1960 ' s for the use
of human subjects in research on the Urbana-Champaign campus remain
unchanged, but the increasing number of such activities, the specific
procedural requirements of certain sponsoring agencies, and the new
statutory requirements necessitate a more formalized process for over-
seeing of the use of human subjects on this campus.
11
To this end, the Institutional Review Board for the University of
Illinois, Urbana-Champaign , was established in 1975, composed of
John D. Anderson, Frederick: C. Fliegel, W. Edward Harris, Lloyd G. Humphreys,
Robert L. Sprague, Esther K. Sleator, and Willard J. Visek as Members,
B. S. Katzenellenbogen, Jeffery T- , Markland, and Joseph E. McGrath as
Alternates anc^ Linda S. Wilson as Executive Secretary. This Board has
undertaken a review of the UIUC policy and procedures to assure their
appropriateness for the nature and increased level of activities involv-
ing human subjects on this campus and to assure compliance with the various
laws and regulations governing such activities.
In the pages which follow, the basic ethical considerations are re-
iterated, definitions are provided, the UIUC policy and procedures are
set forth, and specific instructions to assist investigators in the re-
view process are provided. In addition, the current DHEW regulations
are included for reference.
All of those engaged in work involving human subjects in any component
of the University of Illinois, Urbana-Champaign campus, should become
familiar with and follow the definitions, instructions, policies and pro-
cedures described in this document.
Opportunities abound for research leading to significant improvement
of the quality of human life, especially in a major research university
such as ours. Some of this important work requires the use of human sub-
jects. Careful attention to the responsibility for the rights and welfare
of such subjects is vital both for the subjects themselves and for the
freedom to continue to undertake responsible research involving human
subjects.
I urge your careful study of this document.
/ George//A. RussellVice (Chancellor for Research and
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Part I ETHICAL AND PROFESSIONAL STANDARDS FOR USE OF HUMAN SUBJECTS
IN RESEARCH
The use of human subjects in research can be extremely
important to the development of new knowledge in many areas. Ultimately,
the only sure means for learning specifically about man is through
studying man himself. Responsible investigation involving human beings
as subjects, however, demands that careful attention be r^iven to questions
of ethics and propriety. The ethical and professional standards that
have been widely adopted by investigators conducting studies on human
beings are succinctly stated in the Nuremburg Code: 1
"1. The voluntary consent of the human subject is absolutely
essential
.
2. The experiment should be such as to yield fruitful results
for the good of society, unprocurable by other methods or
means of study, and not random and unnecessary in nature.
3. The experiment should be so designed and based on the
results of animal experimentation and a knowledge of
the natural history of disease or other problem under
study that the anticipated results will justify the
performance of the experiment
.
h. The experiment should be so conducted as to avoid all
unnecessary physical and mental suffering and injury.
5- No experiment should be conducted where there is an a
priori reason to believe that death or disabling injury
will occur; except perhaps in those experiments where
experimental physicians also serve as subjects.
6. The degree of risk to be taken should never exceed that
determined by the humanitarian importance of the
problem to be solved by the experiment.
7- Proper preparations should be made and adequate facilities
provided to protect the experimental subject against
even remote possibilities of injury, disability, or death.
8. The experiment should be conducted only by scientifically
qualified persons. The highest degree of skill and care
should be required through all stages of the experiment
of those who conduct or engage in the experiment.
9- During the course of the experiment, the human subject
should be at liberty to bring the experiment to an end
if he has reached ihe physical or mental state where
continuation of the experiment seems to him to be
impos s ib le
.
1'rrials of War Criminals before the Nuremburg Military Tribunals. Superin-
tendent of Documents, U- S. Government Printing Office, Washington, D.C.
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10. During the course of the experiment, the scientist in
charge must be prepared to terminate the experiment at
any stage, if he has probable cause to believe, in the
exercise of good faith, superior skill, and careful
judgment required of him, that a continuation of the
experiment is likely to result in injury, disability,
or death to the experimental subject."
Various professional associations have also developed and adopted ethical
codes which guide investigators working in the various disciplines in-
volved. Examples of these are:
The Declaration of Helsinki; Recommendations Guiding Doctors in Clinical
Research (1964) , adopted by World Medical Association. ( J. A.M. A. , 197
(1) : 32, Sept. 12, 1966) Copies available from the American Medical
Association, 535 North Dearborn Street, Chicago, Illinois 606IO
.
Professional Ethics - Statements and Procedures of the American Anthro -
pological Association ; September, 1973 -
American Anthropological Association
1703 New Hampshire Ave., N.W.
Washington, D. C 20009
Patients Bill of Rights, November 17, 1972
American Hospital Association, Inc.
1200 Seventeenth St., N.W.
Washington, D. C. 20036
AMA Ethical Guidelines for Clinical Investigation; November 30, 1966
American Medical Association
535 North Dearborn Street
Chicago, Illinois 606IO
The Nurse in Research; ANA Guidelines on Ethical Values; January 1968
American Nurses' Association
10 Columbus Circle
New York, New York 10019
Code of Ethical Standards
American Personnel and Guidance Association
1607 New Hampshire Ave., N.W.
Washington, D. C 20009
Ethical Principles in the Conduct of Research with Human Participants ,
copyright 1973
American Psychological Association, Inc.
1200 17th St. , N.W.
Washington, D. C. 20036
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Code of Ethics of American Sociological Association, September 1, 1971
American Sociological Association
1722 N. Street, N.W.
Washington, D. C. 20036
The Pediatric Bill of Rights, February 2$, 197^
National Association of Children's Hospitals and Related Institutions, Inc.
1308 Delaware Avenue
Wilmington, Delaware 19806
NASW Code of Ethics, October 13, 1968
National Association of Social Workers
2 Park Avenue
New York, New York 100 16
Ethical Standards for Research with Children
Society for Research in Child Development
University of Chicago Press
5801 Ellis Avenue
Chicago, Illinois 60637
Copies of these are available for review in the Office of the Executive
Secretary of the Institutional Review Board, Room 338 Administration
Building and in the University Library; copies may be obtained from the
addresses given above.
The investigator using human subjects should fully familiarize himself
with these ethical considerations and their implications. To this end
the monographs by Beecher and by Ladimer and Newman are strongly
recommended.
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H. K. Beecher, Experimentation in Man. C. C. Thomas, Springfield,
Illinois, 1960.
I. Ladimer, and R. W. Newman, Clinical Investigation in Medicine :
Legal, Ethical, and Moral Aspects . Boston University Law-Medicine
Research Institute, Boston, Massachusetts, 1963.
PART II UIUC POLICY FOR USE OF HUMAN SUBJECTS IN RESEARCH
A. Applicability
Any activity conducted at or sponsored by the University
of Illinois - Urbana-Champaign which involves human subjects*,
i.e. human beings whose physical, emotional, or behavioral condition,
responses, tissues or fluids are investigated for any purpose other
than for the sole purpose of benefitting the subject as an indivi-
dual, must be reviewed.
The use of interviews, tests, observations, and inquiries
designed to elicit non-public information about individuals or groups
must be reviewed. However, routine course development, including
evaluation of the effectiveness of such development, in courses
sponsored by UIUC do not need review. Nor do non-intervening obser-
vations of public behavior, secondary use of data if the subjects
are not identifiable, and use of publicly available data whether
or not the subjects are identifiable.
Research projects, demonstration activities, pilot projects,
student dissertation projects, independent study projects and course
projects must be reviewed if they involve human subjects.
B. Statement of Policy
The University of Illinois - Urbana-Champaign affirms the
need for academic freedom in the conduct of research and the value
of well-designed, responsible activities which involve human subjects.
At the same time it recognizes its basic responsibility to assure
the protection of any human subjects so involved. To this end it has
adopted the following statement of policy:
1. Investigations conducted at or sponsored by the University
of Illinois - Urbana-Champaign must adhere to the principles set
forth in the Nuremburg Code, or one of the ethical codes devel-
oped by the various professional associations, and must adhere
to the policies and procedures set forth in this document.
2. Participation of human beings as subjects in research*
governed by this policy must be voluntary, i.e. it must occur
as the result of free choice without compulsion or obligation.
Both the rights of such individuals to be protected against
injury or invasions of their privacy, and their interests as
members of a free society in preserving their dignity, are recog-
nized as of major concern and must be protected.
Where minors, mentally retarded or mentally disabled persons,
individuals with limited civil freedom, pregnant women, fetuses,
children, or the dead are subjects in an investigation, special
care must be taken to assure that consent* for participation is
obtained from authorized representatives in accordance with appli-
cable statutes and regulations.
* See page 5, Section II C for definition and discussion of the
terms research, subject, risk, and consent.
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3. Projects involving human subjects should be carefully
designed to minimize risk* to the subjects. As far as possi-
ble, any risk should be anticipated in advance. Proper pre-
cautions should be taken and plans made to deal with emergen-
cies that may develop in the course of even seemingly routine
activities.
4. Methods of approaching subjects and securing their partici-
pation must be disclosed in the description of the project sub-
mitted for review by the Institutional Review Board or department
executive officer. No coercion, explicit or implicit, should be
used to obtain or maintain cooperation.
5. Any payment made to subjects should not be large enough to
constitute excessive inducement for participation of subjects.
Plans for payment of subjects must be disclosed in the descrip-
tion of the project submitted for review by the Institutional
Review Board or department executive officer.
The UIUC process for prior review, and timely periodic review
after approval, of research, development and related activities involving
human subjects is for the purpose of assuring independent determination
whether the subjects will be placed at risk, and, if risk is involved,
whether
:
(a) any risks to the subject are so outweighed by the sum of
the benefit to the subject and the importance of the
knowledge to be gained as to warrant a decision to allow
the project to be undertaken ,-
(b) the welfare of any such subjects will be adequately pro-
tected; and
(c) legally effective informed consent will be obtained by
adequate and appropriate methods.
C. Definition of Terms
1. Research
Human beings may be studied in many ways and under a vast
variety of circumstances and conditions. For these reasons the
word "research" is elusive and difficult to define with precision.
On the one hand, research may be used to describe something as
innocuous as a new approach to teaching or the questions in a
public opinion survey. It is also recognized that the subject
may be exposed to the gravest mortal risks, such as the astro-
naut who prepares to be launched into space, to orbit the earth,
or journey to the moon. As used in this document, the word
research is defined as a trial or special observation, usually
made under conditions determined by the investigator, which aims
to test a hypothesis, to discover some unknown principle or
effect, or to illustrate some known or suggested truth. The
term research is intended to apply to systematic studies in which
any substance or stimulus is administered to a subject by any
* See page 5, Section II C for definition and discussion of the
terms research, subject, risk, and consent.
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route. It is intended to apply to studies which involve changes
in physical or psychological state or environment or major changes
in diet and to the pertinent methods for studying alterations in
body functions and behavior under such conditions. It is intended
to apply to the use of interviews, tests, observations and inquiries
designed to elicit nonpublic information about individuals or
groups.
It is not intended to apply to routine course development, inclu-
ding evaluation of the effectiveness of such development, in courses
sponsored by the University of Illinois. Nor is it intended to
apply to non-intervening observation of public behavior, secondary
use of data if the subjects are non-identifiable, or use of publicly
available data whether or not the subjects are identifiable.
2. Subject
There are several types of human subjects. For example, the
subject may be an adult, a minor, a student, a hospitalized patient,
client, a resident of an institution for the mentally ill or retar-
ded, a prison inmate, etc. Donors of organs, tissues, body fluids
and services, and informants are also considered to be subjects.
It is useful to distinguish between normal subjects and those
which are of interest because of an illness or dysfunction they
exhibit. A subject is considered to be a "normal" subject if
his/her participation in the research is not determined by any
illness or dysfunction that he/she exhibits and if his/her health
cannot be foreseen to benefit by participating in the research.
Hospitalized patients volunteering to participate in research
that bears no relationship to their illness or its treatment may
be regarded by the investigator as "normal volunteers."
Of particular concern are the following types of subjects:
a) Subjects with limited civil freedom, such as prisoners,
residents or clients of institutions for the mentally ill
and mentally retarded, and persons subject to military
discipline.
b) Pregnant women, the viable fetus (both in utero and ex
utero) , the newborn, children, minors and the dead. (the
unborn and the dead should be considered subjects to the
extent that they have rights that can be exercised by
their next of kin or legally authorized representative.)
The definition of subject excludes all accepted and estab-
lished service relationships, such as the normal relationship
of patients to physicians, students to professors, and other clients
to professionals in which the patient, student or client is receiv-
ing aid or services consistent with accepted and established prac-
tice, and intended only to meet hi s own personal needs . The pro-
fessional-client relationship has the welfare of the client as the
primary objective, whereas the investigator-subject relationship
has the discovery of new knowledge as its primary objective. This
difference may not be fully understood by the subject who is also a
client, and can result in the investigator's gaining consent with-
out free decision, in part due to a trust based on a presumed role
which the investigator is not necessarily fulfilling at that time.
The normal employee-employer relationship, in which legitimate
services are rendered for salary, wages or remuneration in keeping
with customary written or verbal contracts, is also excluded from
the definition of subject.* If doubt exists as to whether the pro-
cedures to be employed are within accepted and established practice
or as to whether the purpose is only for the personal needs of the
client, the activity should be considered to involve subjects whose
rights and welfare are to be protected in accord with this policy
statement. Similarly, if doubt exists as to whether the procedures
are within the normal limits of the employee's work scope, employees
should be considered to be participating as human subjects, and their
rights and welfare must be protected.
Types of Risks
There are different risks inherent in different research
procedures.
Risk is most obvious in medical and behavioral science re-
search projects involving procedures which may induce a poten-
tially harmful altered physical state or condition: surgical and
biopsy procedures; the removal of organs or tissues for study,
reference, transplantation, or banking; the administration of
drugs or radiation; the use of indwelling catheters or electrodes;
the requirement of strenuous physical exertion; subjection to
deceit, public embarrassment, and humiliation.
There is a wide range of medical, social, and behavioral
projects and activities in which no immediate physical risk to
the subject is involved, e.g., those involving the use of person-
ality inventories, interviews, questionnaires, observation, photo-
graphs, taped records, and stored data. However, some of these
procedures may involve varying degrees of discomfort, harassment,
invasion of privacy, or may constitute a threat to the subject's
dignity through the imposition of demeaning conditions.
There are also medical and biomedical projects concerned solely
with organs, tissues, body fluids, and other materials obtained in
the course of routine performance of medical services such as diag-
nosis, treatment and care, or an autopsy. The use of these mate-
rials obviously involves no element of physical risk to the sub-
ject. However, their use for many research, training, and service
purposes may present psychological, social, or legal risks to the
subject. In these cases, review is necessary to determine that
the circumstances under which the materials were procured were
appropriate and that adequate and appropriate consent was , or can
be, obtained for the use of these materials for project purposes.
Some studies depend upon stored data or information which was
obtained for different purposes.
a) If the material to be used in the research involves
identifiable subjects , the review of the risk involved
must include a determination of whether the use of these
materials is within the scope of the original consent,
whether consent is necessary, and whether it can be obtained.
b) If the material to be used in the research does not involve
identifiable subjects, no review is necessary.
*Payment of subjects does not alter their status as subjects.
Certain risks are inherent in life itself, at the time and
in the places where life runs its course. Risks of everyday
living include the ordinary risks of public or private living;
those risks associated with admission to a school or hospital;
and the risk inherent in professional practice, as long as these
do not exceed the bounds of established and accepted procedures,
including innovative practices applied in the interest of the
individual patient, student, or client.
Any activities which expose the subject to significant
physical risk require special consideration. The investigator
and those who review his plans should carefully weigh whether
supervision of a physician is advisable. In cases where a
physician's supervision or availability is deemed advisable,
the individual investigator shall have the responsibility to
make the necessary arrangements to provide for it. The fact
that some types of experimentation do not involve risks beyond
those experienced in ordinary life situations does not mean




The ethical and professional codes governing the use of human
subjects in research provide that no research involving human sub-
jects as governed by this document should be undertaken without
the voluntary consent of the human subject, or from his/her author-
ized representative if the subject lacks the capacity to consent.
When the research does not place the subjects at risk, there
is no single method required to assure that the subject consents
to participation. The subject's consent may, for example, be
secured via a written document, it may be obtained orally, it may
be implicit in voluntary participation in a well-advertised activity.
However the subject's consent is obtained, it must be "informed"
consent, i.e., the knowing consent of an individual or his/her
legally authorized representative, so situated as to be able to
exercise free power of choice without the presence of excessive
inducement or any element of force, fraud, deceit, duress, or other
form of restraint or coercion.
A dilemma arises because in some research, fully informing the
subjects would invalidate the experiment. If it is necessary to
withhold information from the subject, the investigator must care-
fully inform the reviewers of what information will be withheld
from the subjects and must clearly justify the withholding of infor-
mation. Debriefing procedures to be used must also be described
to reviewers. The reviewers must then decide whether the justifica-
tion is sufficient and whether the subjects' rights and welfare are
adequately protected. Nondisclosure of information to subjects must
not be used simply to assure their participation in the research .
Investigators proposing to place any subject at risk are
obligated to obtain legally effective informed consent. The basic
elements of information necessary to such consent include:
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(i) A fair explanation of the procedures to be followed,
and their purposes, including identification of any
procedures which are experimental
;
(ii) A description of any attendant discomforts and risks
reasonably to be expected;
(iii) A description of any benefits reasonably to be expected;
(iv) A disclosure of any appropriate alternative procedures
that might be advantageous for the subject;
(v) An offer to answer any inquiries concerning the procedures;
and
(vi) An instruction that the individual is free to withdraw
his consent and to discontinue participation in the pro-
ject or activity at any time without prejudice to the
subject.
It is best to use a written document in obtaining the consent
of subjects to be placed at risk. Whether the consent is obtained
via a written document or is obtained orally, it must include all
of the basic elements of informed consent described above and some
documentation of consent must be kept in the investigator's records.
The use of methods other than a written document is sometimes more
appropriate. In such cases, the method to be used must be described
and justified in the material submitted for review. Occasionally,
fully informed consent may itself have injurious effects on the sub-
ject, or it may invalidate the experiment, as in the use of place-
boes or double blind studies. If information is to be withheld from
the subject, the investigator must inform the reviewers what infor-
mation will be withheld from the subjects, justify the withholding
of information, and describe any debriefing procedures to be followed.
The reviewers must consider this information and decide whether the
withholding of information is justified and whether the subjects'
rights and welfare are adequately protected. Nondisclosure of
information must not be used to secure the participation of subjects .
Note: However informed consent is obtained, and whether or not
subjects will be placed at risk , no exculpatory language
may be included through which the subject is made to
waive, or appear to waive, any of his/her legal rights,
including any release of the University or its agents
from liability or negligence.
Note: Special procedures for obtaining and documenting informed
consent of subjects placed at risk in activities supported
by DHEW and certain other sponsoring agencies. See Appen-
dix D, Sections 46.9 and 46.10 for these requirements.
Appendix A contains samples of basic informed consent documents
and instructions for their use. It should be realized that the con-
sent form is not a release. As mentioned above, it must not con-
tain exculpatory language. The signed consent form is simply evi-
dence of disclosure of essential information necessary to obtain
an informed consent.
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5. Confidentiality of Data
Both the rights of the subjects to be protected against
injury or illegal invasions of their privacy and their interests
as members of a free society in preserving their dignity, are
recognized as of major concern and must be protected. The more
sensitive the material, the greater the care that must be exer-
cised in obtaining, handling and storing data. Provisions rela-
ting to the degree and kind of confidentiality of data and
anonymity of the subjects must be specified in the description
of the project submitted for review. Ordinarily, the following
requirements must be met, subject only to their appropriateness
to the particular activity:
a. Questionnaires, inventories, interview schedules, and
other data gathering instruments and procedures should be
carefully designed to limit the personal information to
be acquired to that absolutely essential to the activity.
b. Data that include information which would reveal a subject's
identity should be stored in files accessible only to the
project investigator and his/her authorized staff or repre-
sentatives.
c. As early as feasible, the data should be handled in coded
form, i.e., the subject's name and information that would
reveal his/her identity should be removed. Plans for the
ultimate disposition of the data should be made.
d. The identity of subjects must not be released except with
their express permission.
e. Use of stored data or information originally obtained
for different purposes which involves identifiable sub-
jects, requires examination of the risk involved, a
determination of whether the new use is within the scope
of the original consent or whether obtaining additional
consent is necessary and feasible, and provision for the
preservation of anonymity of the subjects.
Data that are part of the public domain are not covered by
the foregoing restrictions.
D. Classification of Circumstances Involving Human Subjects
Human subjects at the University of Illinois participate in a
great variety of experimental circumstances ranging from classroom
demonstrations where there are no risks beyond those associated with
customary work-a-day existence to experimental studies of drugs,
vaccines, radioactive materials, and severe physiological stresses
where there is a definite risk. For the purposes of safeguarding the
human volunteers and assuring that these safeguards are continuously
provided, the circumstances where human subjects are used may be
grouped into two categories:
-11-
1. Subjects engage in activities with customary everyday
risks.
2. Subjects engage in activities where the risk is greater
than that encountered in ordinary conditions and customary
activities. All research protocols that involve procedures
that may induce potentially harmful, altered psychological
or physical states or conditions, untried diagnostic
and surgical procedures or devices, biopsy procedures,
removal of organs or tissues for study, reference, trans-
plantation or banking, administration of drugs or radia-
tion, use of in-dwelling catheters or in-dwelling elec-
trodes, and procedures which require strenuous physical
exertion, fall in this category.
Several examples of uses of human subjects are cited in Tables
1 and 2, pages 12 and 13, where the circumstances are classified according to
these two categories. These examples, which are merely illustrative,
should serve as guides for the classification of future studies invol-
ving human subjects. In classifying research involving human subjects,
the investigator and those who review the proposed use of subjects,
should not simply attempt to identify the research with these examples,
hut should follow the principles and procedures of this document in
arriving at a carefully reasoned decision.
The two categories of activities involving human subjects
described above require different safeguards for the rights and welfare
of the subjects. Investigators, deans, directors, and department heads
are responsible for assuring that these safeguards are provided accord-
ingly .
Category 1 Activities involving risks of ordinary life
(Subjects considered to be "not at risk")
1. Participation must be voluntary, but signed, written consent
forms are not required.
2. All volunteer subjects should be able to state that they
have no disorder or defect contraindicating their participation in
the proposed project.
3. The project must be supervised by a qualified faculty or
staff member.
Category 2 Activities involving risks greater than those of ordinary life
(Subjects considered to be "at risk")
1. Participation must be voluntary and signed written con-
sent forms are considered mandatory, unless another method for
obtaining consent is specifically approved by the IRB.
2. A written record of the experiments detailing the procedures
employed and the results obtained shall be made and kept for reference.
-12-
3. The project must be supervised by a qualified faculty or
staff member.
4. When the risk involved is a significant physical risk, the
investigator and those who review his/her plans must determine:
a) Whether it will be necessary for the subjects' physical
condition to be evaluated by a licensed physician who
is acquainted with the possible hazards of the proposed
investigations;
b) Whether supervision or ready availability of a physician
is advisable for the project.
5- No form of radioactive material may be experimentally
administered to human volunteers without the authorization of the
persons responsible to the University for the appropriate and safe
use of radioactive materials.
6- No Investigational New Drugs ( drugs not certified by
FDA for clinical use) may be administered without compliance
with the FDA requirements, which include appropriate notifi-
cation to FDA and receipt of either a waiver or permission
(and an IND number).
NOTE: Where human experimentation forms an integral part of
the conduct of a course of instruction, the official
University bulletins and timetables should state the fact
in the description of the course. A statement such as
"Includes limited voluntary participation as a subject
in experiments" should be a part of the course descrip -
tion. This statement would serve to alert registrants
of this characteristic of the course, but would not suf-
fice as the only means of assuring that the subjects'
participation in individual experiments is voluntary. Care
must be exercised to assure the absence of coercion, either
real or perceived, in utilizing students as subjects.
Table 1. Examples of Research in Category 1
1. Studies of the psychological and physiological effects of
mild to moderate sleep loss.
2. Studies of movement and moderate exercise of asymptomatic
children and young adults where adverse effects are not
anticipated.
3. Classroom demonstrations and experiments on physiological
responses to moderate exercise, mild thermal stress, breathing
atmospheres with slightly reduced oxygen or slightly elevated
carbon dioxide, etc.
4. Most psychological studies of learning, conditioning, sensory
perception, personality, and group situations.
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5. Psychological and judgment responses to speech.
6. Psycho-social studies of childhood obesity.
7- Behavioral studies of -hi Id development.
8_ Corrective therapeutic exercise,
9 Industrial work studies with mild to moderate work load and mild
to moderate thermal stress.
10. Clothing and textile studies under conditions of mild to moderate
thermal stress.
11. Psychological studies of hypnosis where the subjects are not sub-
jected to physiological or emotional stress. In this context the
volunteer under hypnosis will not be asked personal questions
which relate to his private life.
12. Nutritional studies in which the subjects are expected to ingest nei-
ther unusual diets nor diets which are deficient in essential nutrients
13. Taste panel studies and taste tests.
Table 2. Examples of Research in Category 2
1. Simulated high altitude flights.
2. Psychological studies of hypnosis where subjects are subjected
to physiological or emotional stress.
3- Adult exercise and fitness testing where the imposed work load
exceeds by about 200 per cent the customary work of the
individual.
h. Industrial work studies where there is hard physical work and
high environmental temperature.
5- Physiological studies of sweating involving special nutrient
regimens, dehydration, and work in thermally stressful
surroundings
.
6. Pharmacological studies of prescribed drugs.
7- Studies of cold viruses, vaccines, and antibiotics.
8. Studies of prescribed tranquilizer drugs on driving skills.
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Part III ADMINISTRATION OF STANDARDS AND SAFEGUARDS
A. The UIUC Institutional Review Board
1. Origin of the IRB
The long established UIUC principles for responsible use of
human subjects in experimentation were originally administered in
a totally decentralized manner consistent with the relatively low
level of such activities and the decentralized nature of the
institution. Later smaLl review committees selected from a roster
of informed and competent professionals in appropriate disciplines,
supplemented the departmental review of activities involving
human subjects sponsored by the Public Health Service, or the
U. S. Department of Agriculture. The increase in the level of
such activities and the increasing specificity of sponsoring
agencies' regulations led to the establishment of a single
Institutional Review Board in the Fall of 1975.
2. Composition of the IRB, and Selection of its Members
The UIUC Institutional Review Board consists of at least five
members, two of whom are licensed to practice medicine, two of whom
have competence in the behavioral sciences or related specialties,
such as anthropology, psychiatry, psychology, and sociology, and
and at least one of whom is not an employee of the University of
Illinois. Each member has a designated Alternate. Members of the
Board and their Alternates are appointed by the Vice Chancellor for
Research for specified overlapping terms so that continuity and
experience is assured. Information on the current composition of
the Board may be obtained from the Executive Secretary of the
Institutional Review Board.
3. Meetings of the IRB
The IRB meets regularly, normally at least monthly, to review
proposed and continuing activities involving human subjects and to
carry out its various responsibilities, as described later in this
document. The quorum is defined to be a simple majority of the
number of Members of the IRB. Alternates may serve for Members in
their absence, are invited to attend all meetings of the Board,
and are kept well informed concerning the Board's policies and
procedures, and the applicable laws and regulations. No member or
Alternate shall be involved in either the initial cr continuing
review of an activity in which he/she has a conflicting interest,
except to provide information requested by the Board.
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4. Role of the IRB
The Institutional Review Board serves as the primary locus of
institutional authority and responsibility for activities involving
the use of human subjects. Its responsibilities include:
(a) Development of policy and procedures for review of such
activities
(b) Development of information and instructions for investi-
gators, reviewers and subjects involved with such activities
(c) Initial and continuing review of such activities
(d) Documentation of review of such activities in conformity
with applicable law, regulations and policies
(e) Provision of advice and counsel to investigators engaged
in such activities
(f) Adjudication of differences and review of problems arising
out of such activities
As such it serves the needs of a large complex institution and
satisfies the DHEW regulations which require that any institution
undertaking DHEW supported research, development and related activities
in which human subjects are involved must provide certain assurances,
meet certain standards and establish an Institutional Review Board to
conduct initial and continuing reviews of such activities in accordance
with the regulations. It satisfies the regulations of the USDA and
various other federal and non-federal agencies which require adherence
to the DHEW regulations on protection of human subjects. And it also
satisfies the broader requirement of the National Research Service Award
Act of 1974 (Public Law 93-348) which stipulates that any entity which
applies for a DHEW grant or contract to support a project must establish
an Institutional Review Board to review biomedical and behavioral research
conducted at or sponsored by such entity in order to protect the rights
of the human subjects.
B. Responsibility for Compliance with Ethical Standards and UIUC Policy
The ethical and professional standards governing the use of human
subjects in experimentation are described in Part I of this document. Part
II set forth the University's policy in these matters and provided defini-
tions of commonly used terms. The responsibility for compliance with these
standards and the UIUC policy lies as follows:
a) The responsibility to initiate the review process and the responsi-
bility for day to day assurance of protection of the rights and
welfare of human subjects both lie with the individual (s) respon-
sible for the conduct of the activity, i.e., the project or pro-
gram director, principal investigator, fellow, trainee, or student
undertaking the activity.
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b) If the individual responsible for conduct of the activity
is not a UIUC employee or student, but is obtaining access
to subjects through the UIUC, the individual providing access
to the subjects is responsible to assure that UIUC guidelines,
including review, are met.
c) The responsibility for the initial and continuing reviews
must fall also on persons both knowledgeable about the
University's policy and relevant regulations and in a
position to make an independent, objective determination
that the activity is consistent with the University's
Guidelines, i.e., with the departmental executive officer,
the Institutional Review Board and its Advisory Committees.
Many UIUC activities involve interaction between an "investi-
gator" and human beings. For some of these activities the responsibility
for appropriate review and supervision to assure that the rights and wel-
fare of the human beings involved are protected, has already been estab-
lished. Duplicative review by the Institutional Review Board would serve
no useful purpose. For some activities the nature of the activities is
such that individual review is unnecessary and only the criteria by
which review of such activities is judged unnecessary needs review by
the IRB. For still others, the nature of the activities is such that
individual review is necessary. Guidelines are therefore necessary for
deciding which UIUC activities fall within each of these categories.
Section C (below) presents the guidelines for deciding whether
and what kind of Institutional Review Board review is required. Section
D (below) presents the specific review procedures to be followed for
the various categories of activities involving human subjects. Appendix
E provides Instructions for Investigators.
NOTE : Anyone conducting a study using human subjects
which has not been reviewed and approved as
specified herein is in violation of University
policy and the applicable laws and regulations .
B tra <* fcB* **/«*•*.;W*yte*«JM to*-*
Guidelines for Determining Whether and What Kind of IRB Review
is Required
Activities involving human beings which do not require
Institutional Review Board review .
The following types of activities already have an established
assignment of review and supervision adequate to assure that the
rights and welfare of the human beings are protected:
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Type of Activity
Projects undertaken by faculty
or administration involving
student or employee records.
Accepted and established
service relationships (such
as the normal relationship
of patients to physicians
students to professors, and
other clients to profes-
sionals) in which the patient,
student or client is re-
ceiving aid or services in-
tended only to meet his/her own
personal needs .
The normal employer-employee
relationship in which legit-
imate services are rendered
for salary, wages, or re-
muneration in keeping with
customary written or verbal
contracts, except of course
when the purpose of employ-
ment is service as a subject.
Payment of subjects does not
alter their status as subjects.
It should be noted that any
of the relationships can be
converted into an investigator-
subject relationship if the
client's benefit and welfare
is not the overriding purpose
of the service performed, or
if the procedures are not
within the normal limits of
the employee's work scope.
In such instances, the activity
would need to be reviewed by
the Institutional Review
Board and would fall in either
category 2 or 3 described below.
Respons ibility
University policy restricts access to
student and employee records. Specific
individuals have been assigned respon-
sibility for assuring privacy, and
guidelines have been set for deter-
mining who may gain access, under what
conditions and for what purposes.
Professional and ethical codes govern
these relationships. Training in the
professions is supervised by profes-
sionals who have the responsibility to
assure protection of rights and wel-
fare of clients involved.
Activities involving human subjects which require Institutional
Review Board review collectively, but not individually .
A large number of activities involving human subjects at no risk
beyond those of ordinary life are undertaken each year without exter-
nal funding . Some are, for example, part of introductory and re-
search methods courses; some are short term pilot projects, doctoral
dissertations and independent study projects. Some are regular
faculty research projects. Some involve new use of previously gath-
ered data on human subjects.
The large volume of such activities, the fact that for most of
these, any risks to the human subjects fall well within the risks of
ordinary life, and the fact that for many the time available for review
is extremely short, dictate that review be expeditious and simple as well
as responsible.
Review of such activities may be handled by the establishment
of departmental guidelines on the basis of the recurring types of
"ordinary risk" activities undertaken by the department and the well
established and accepted professional procedures used in the department.
When such Guidelines have been approved by the Institutional Review Board,
activities involving human subjects, which are not externally funded, and
which fall within the Guidelines, would not need to be reviewed individ-
ually by the IRB.
Departments wishing to use this review mechanism must submit
written guidelines to the IRB which will review them to be sure that the
IRB's responsibilities can be fulfilled. Appendix B of this document
sets forth specific requirements for the content of departmental guide-
lines.
The review procedure for activities in this category is described
in Section D 2 below.
Research involving human subjects which require Institutional
Review Board review .
The following types of activities require Institutional Review
Board review:
a. Research which is carried out without external support
and which does not fall within departmental guidelines
approved by IRB.
b. Research activities supported by, or proposed for support
from, external sponsors.
c. Any activities which do not require IRB review, but for
which IRB review is requested by the investigator or the
institution.
The review procedure for activities in this category are
described in Section D 3 below.
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D. Review Procedures
































NOTE: Externally funded activities and activities involving subjects
"at risk" by definition do not fall within approved departmental
guidelines.
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Procedures for activities which fall within departmental guide-
lines approved by IRB .
a. All activities involving human subjects must be supervised by
competent staff members.
b. Before any project using human subjects can be initiated, the
investigator, or in the case of a student project, the super-
vising staff member, must provide to the executive officer
of his/her unit a description of the proposed activity in-
cluding:
i) description of subjects to be used and how they will be
obtained
ii) description of the planned use of human subjects
iii) description of the risks involved and benefits to be
obtained
iv) description of the procedures to insure protection of the
human subjects, including the methods to be used to assure
informed consent and confidentiality of data.
For detailed instructions see Appendix E, Instructions
for Investigators
c. The executive officer, or the individual (s) designated by him/her
to carry out this function, will review the proposed activity
to insure that it is in accordance with the departmental
guidelines approved by the Institutional Review Board. If
he/she finds that the project does not comply with the IRB
approved departmental guidelines, he/she will inform the
investigator that IRB review is necessary and that no work
with human subjects may take place until the proposed activity
has received IRB approval.
At his/her discretion the executive officer may also request IRB
review of projects which do fall within IRB approved depart-
mental guidelines.
The formality with which the departmental review will be
conducted will be left to the discretion of the unit executive
officer. At his/her option, "Information for Review of Activity
Involving Human Subjects" (Form IRB-1, See Appendix C), with
attachments may be used to provide information for review.
NOTE: If the proposed activity will be undertaken or supervised
by the unit executive officer, the description of the
proposed project must be forwarded to the Secretary of
the Institutional Review Board who will undertake the
review normally carried out by the unit executive officer.
-21-
d. If the unit executive officer refuses to approve a project
proposed by a Responsible Project Investigator, and the RPI
believes the study is in conformity with university policy
regarding the use of human subjects, the RPI may appeal that
decision directly to the Institutional Review Board. The
IRB will then conduct a review of the proposed study and
render a decision.
e. The nature of the documentation of the departmental reviews
is left to the discretion of the unit executive officer, but
must be sufficient for reports to be made to the IRB on the
department's experience with this procedure.
f. The investigator is responsible for insuring that the proce-
dures are carried out as approved, for requesting another
review by his/her unit executive officer if significant changes
in procedure are needed, for requesting annual reviews of pro-
jects which continue longer than one year, and for notifying
the unit executive officer if any problems arise involving
human subjects.
g. The unit executive officer is responsible for conducting
further reviews if changes are proposed, for up-dating
reviews of projects continuing longer than one year, and for
notifying the Institutional Review Board of any problems
which arise involving human subjects.
Procedures for Activities which do not fall within the IRB
approved departmental guidelines and for activities which are
supported by, or proposed for support by external sponsors.
These procedures cover all such projects done at the University
or under the auspices of the University. Thus projects carried
out by the faculty, students or staff, projects done as theses
or dissertations, projects done as part of a course or inde-
pendent study, are all included regardless of the type of
sponsored agreement (i.e., research grant, contract, training
grant, fellowship, research career development award, etc.)
involved if externally funded.
Before any such research, development or related activity can be
reviewed and approved, it must have associated with it a Re-
sponsible Project Investigator (RPI) who is a qualified faculty
member at or above the level of instructor or qualified staff mem-
ber and who will monitor the conduct of the activity.
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c. Before any project using human subjects can be initiated the
faculty or staff member who is the Responsible Project Inves-
tigator (RPI) must submit to the Executive Secretary of the IRB
eleven (11) copies of Form IRB-1 ("Information for Review of
Activity Involving Human Subjects," see Appendix C) with
appropriate attachments providing the protocol of the planned
use of human subjects, description of the subjects to be used
and the method to be used to obtain them, a description of the
inherent risks and benefits involved, if any, and a descrip-
tion of the procedures which will be followed to insure the
protection of the human subjects, including the methods to be
used to assure informed consent and confidentiality of data.
For detailed instructions, see Appendix E Instructions for
Investigators
.
If the project is being proposed for external support, the IRB-1
forms and attachments should be submitted to the Secretary of
the IRB well in advance of the deadline for submission of the
application to the sponsor, and certainly no later than simul-
taneously with submission of the application for review through
the campus administrative channels. Advance submission gives
the investigator the benefit of review prior to the preparation
of the final form of the application, thus insuring that any
procedural revisions required by the IRB will not delay sub-
mission.
d. Before approving the Proposal Transmittal Form* attached to
proposals to external sponsors, the unit executive officer will
check to see whether the project involves human subjects and
that the form is properly marked with regard to the use of
human subjects.
e. The Secretary of the University Research Board, and others desig-
nated by the Chairman of the Research Board, who review for the
Board all proposals submitted to external agencies will check
each proposal to make sure that those which involve the use of
human subjects are identified.
f. The Institutional Review Board will review all such projects.
At its discretion the Institutional Review Board may seek the
advice of members of one or more of the Advisory Committees
established for this purpose. The Institutional Review Board
will normally seek such advice on all projects in which the
subjects are "at risk" and for projects to be undertaken with
DHEW or USDA support. The Board may accept or reject the advice
of the Advisory Committee members in taking its action on a
proposed activity.
*The Proposal Transmittal Form is the internal form which accompanies each
proposal for external support as it is routed through campus administra-
tion channels.
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g. The Secretary of the IRB will inform the investigator, the
department, and the sponsor if required, of the action of the
IRB. In notifying an investigator of approval by the IRB,
the Secretary informs the investigator of any special require-
ments set by the IRB. The notification will also state again
the requirements for prior review of any changes in procedures
involving human subjects and for additional review as stipu-
lated by the IRB (at least annual review is required).
Within eight months of the notification of approval, the
Secretary of IRB will again notify the investigator of the need
to keep the IRB informed of his/her plans, including any changes
in procedures, so that a new review can be made within one year
from the current IRB approval and so that any application for
extension or continuation of support can be considered by the
IRB well in advance of its effective date. Where more frequent
than annual review is deemed advisable by the IRB, the investi-
gator will be so informed and the follow-up procedures will
be adjusted accordingly.
h. The Responsible Project Investigator is responsible for insuring
that the procedures are carried out as approved, for requesting
another review if significant changes in procedure are needed,
for requesting annual reviews of any projects which continue
longer than one year, and for notifying the unit executive
officer if any problems arise involving human subjects.
i. The unit executive officer is responsible for notifying the
IRB of any problems which arise involving human subjects.
E. Special Procedures for Applications and Proposals Lacking
Definite Plans for Involvement of Human Subj ects
Certain types of activities are planned and initiated with the
knowledge that human subjects will be involved in the project, but with-
out definite plans for protocols to be followed. PJxamples of such pro-
posed activities are:
1) training programs in which individual training projects
remain to be selected or designed;
2) research, pilot, or developmental studies in which the
involvement of human subjects depends upon such things as
the completion of survey instruments, prior animal studies,
or the purification of compounds.
3) general support programs where selection of the project
is the responsibility of the institution or administrator
of the program rather than the funding agency.
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Such proposed activities will be reviewed initially in the
same way as are activities with fully developed plans, but addi-
tional review will be required when the plans are fully designed. It
is the investigator's responsibility to submit the plans for review
when they are developed. No work involving human subjects may proceed
without prior review of the procedure to be followed.
In activities supported by DHEW, a separate certification
must be submitted to DHEW for each project for which plans for the use of
human subjects are completed after the initial review.
In some activities of this type, the number of separate pro-
jects is large, the number of different protocols involving human sub-
jects is small, and the subjects involved are not at risk. To facilitate
responsible review of such individual projects under externally funded
programs, the IRB delegates to the unit executive officer the responsi-
bility to review the individual projects if the following conditions
are met :
a) The protocol for use of human subjects has been reviewed
and approved by the IRB within the year.
b) The nature of the subject population to be used does not
alter the classification of "not at risk."
If these conditions are not met, the project must be individually
reviewed by the IRB.
When the unit executive officer performs this review for the IRB,
he/she will provide the following information to the Executive Secretary
of the IRB for each such project:
a) Name of project director (and responsible faculty supervisor,
if project director is not a faculty member)
b) Identification of protocol to be used, indicating name of
investigator for whom it was reviewed and approved by IRB
c) Title of project to be undertaken
d) Name of external sponsoring agency and identifying number
of grant or contract
e) If activity is sponsored by DHEW, a DHEW form 596 (copies
available from Executive Secretary of the IRB) completed
through item 3.
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F. Special Procedures to be Used When Access to Subjects is
Gained through a Cooperating Institution .
Investigators at UIUC may gain access to subjects through
cooperating institutions. For example, a UIUC investigator may arrange
with a physician at a local hospital to obtain surgical tissue or body
fluid taken from the donor for therapeutic or diagnostic purposes.
Where the identity of the donor remains unknown to the investigator,
the physician obtains the patient's written consent for the procedure
including the use of such material for study (as covered in the uniform
anatomical gift act), and there is no risk to the donor, no special pro-
cedures are required. However, UIUC investigators should make sure that
an authorized official of the cooperating institution is informed of the
cooperative arrangement. Another example which occurs frequently on the
UIUC campus is the use of school children as subjects. Here again, the
investigator should always make sure that the authorized school officials
are informed of the project. If the subjects are at risk, the consent of
the subject's parent or guardian is required.
In any situations in which subjects at a cooperating institution
will be placed at risk, the following information must be submitted to the
IRB for review:
INSTITUTIONAL AUTHORIZATION FOR ACCESS TO SUBJECTS
Status of Subjects: £J Wards /~7 Residents CJ Employees
n Patients /Z7 Students EJ Other (explain)
Number of Subjects: Age Range of Subjects:












Whenever the nature of the project is such that the situation
is deemed sensitive (as when anonymous donors in a cooperating institu-
tion provide fetal material or the investigator's interest in body fluids
is in restricted drug metabolites), special precautions may be required
whether or not the subjects are at risk.
G. Retention of Records
Copies of all documents presented or required for initial and
continuing review by the Institutional Review Board, such as:
• IRB meeting minutes
• Documents presented for review
• Transmittals of IRB actions, instructions and
conditions resulting from IRB deliberations
• Records of consent for subjects at risk
will be retained by the UIUC, subject to the terms and conditions of the
grant or contract supporting the project, if any. As long as the Respon-
sible Project Investigator remains at UIUC, he/she will store the records
of subjects' consent. All other documents will be stored in the Office of
the Executive Secretary of the Institutional Review Board. If the Respon-
sible Project Investigator leaves the UIUC, the records of subjects' con-
sent must either be turned over to the Executive Secretary of the Institu-
tional Review Board or if the project will be continuing, to the succeeding
Responsible Project Investigator. In the latter case, the IRB must be noti-
fied of the change in Responsible Project Investigator.
Usually a period of five years beyond the expiration of the
project support in the case of an externally funded project, or five years
beyond the termination of the project in a non-externally funded activity,
will be sufficient for compliance with the institution's responsibilities.
However, cognizance should be taken of the implications of the
Illinois statute of limitations and discovery. Legal counsel is deemed
advisable. xt should be noted that consent and other important records
relating to the use of minors as subjects should be kept until at least
two years after the minor reaches majority.
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H . Institutional Review Board Responsibilities
1. Activities which require Institutional Review Board review collec -
tively, but not individually.
The Institutional Review Board will review guidelines proposed
by departments or units for activities which involve subjects at no risk
beyond those of ordinary life and which are undertaken without external
funding. The specific requirements for such departmental guidelines are
set forth in Appendix B.
2
.
Activities involving human subjects which require Institutional
Review Board review individually .
The Institutional Review Board will examine the material sub-
mitted by the investigator (Form IRB-1 and attachments) . At its dis-
cretion the IRB may request additional information from the investigator
to be submitted either orally or in writing and/or the IRB or its
Advisory Committee may arrange to discuss the proposed activity with the
investigator.
The Institutional Review Board will determine whether subjects
will be placed at risk, and if risk is involved, whether
a) the risks to the subjects are so out weighed by the sum of
the benefit to the subject and the importance of the know-
ledge to be gained as to warrant a decision to allow the
project to be undertaken;
b) the rights and welfare of any such subjects will be adequately
protected
;
c) legally effective informed consent will be obtained by
adequate and appropriate methods in accordance with applic-
able policy, laws and regulations.
At its discretion the Institutional Review Board may seek the
advice of members of one or more of the Advisory Committees established
for this purpose. These Advisory Committees are each composed of in-
dividuals selected for their familiarity with research in specified areas
and also individuals who can provide the perspective of other disciplines,
The Board may accept or reject the advice of the Advisory Committee
members in taking its action on the proposal.
The Executive Secretary of the Institutional Review Board will
inform the investigator, the department s and where required, appropriate
office of DHEW or other sponsoring agencies, of the determination by the
Institutional Review Board. When an application must be submitted to an
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external agency prior to completion of the IRB review of the use of
human subjects, the Executive Secretary may inform the agency that re-
view is pending, indicating the date at which the IRB review is expected
to be completed. The final disposition of the review will be promptly
forwarded to the external agency, whatever the outcome.
All projects will receive at least an annual review. When the
Institutional Review Board feels that the element of risk warrants an
earlier review it may specify a specific review date or it may specify
a stage of progress in the study at which a further review will be re-
quired. When the nature of the subjects or project is such that closer
monitoring of the project is deemed advisable by the IRB or required by
the funding agency, the IRB will specify the procedures to be followed
in accomplishing the review. IRB approval of a project signifies that
such matters have been considered and that the project is in compliance
with applicable policies and regulations.
3. Adjudication of Differences and Review of Problems.
The Institutional Review Board will adjudicate matters involv-
ing human subjects in which the investigator and either the unit executive
officer or Advisory Committee disagree.
The Institutional Review Board will review all problems involv-
ing human subjects and will be available to hear any complaints or con-
cerns raised by subjects. On the basis of this review, the IRB will in-
dicate the appropriate action to be taken, if any.
4
.
Documentation of Review .
The Executive Secretary of the Institutional Review Board will
keep appropriate and informative records of the IRB's review of applica-
tions and activities, and other documentation as required by external
sponsors and applicable laws and regulations.
5. Development of Information for Investigators, Reviewers, and Subjects.
The Secretary of the Institutional Review Board, working with
IRB, will see that the information provided to departments, investigators,
and reviewers is adequate and up to date, and will make sure that such
information is accessible to subjects and prospective subjects.
Copies of this document, the UIUC General Assurance submitted
to DHEW, and the various ethical codes referenced in Part I of this docu-
ment will be on file in the Reference Department of the University Library
and in the Office of the Executive Secretary of the Institutional Review
Board. Copies of this document will be made available to the departments
for distribution to investigators and also to subjects and prospective
subjects upon their request.
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6. Development of Policy and Procedures.
The Institutional Review Board also has responsibility for the
development of new or revised policy and procedures to assure protection
of human subjects, as necessary.
I . Investigator's Responsibilities
Each investigator is responsible for:
1. being thoroughly familiar with
a) the University's policy and the definitions of commonly used
terms, as set forth in Part II of this document
b) the Instructions for Investigators in Appendix E of this
document
c) applicable regulations of any external agencies providing
support for the activity
d) applicable policies of any cooperating institutions allowing
access to subjects
2. Providing the information required and taking all the steps indicated
in the appropriate procedure described in PartJII, Section D of this
document for initial and continuing review.
3. Maintaining records of informed consent for subjects at risk in com-
pliance with applicable laws and regulations.
4. Protecting rights and welfare of the human subjects involved in his/
her projects.
J. Unit Executive Officer's Responsibilities
The Unit Executive Officer has responsibility for:
1. Developing Departmental Guidelines, if appropriate, and submitting
them to IRB for review.
2. Reviewing non-externally funded activities involving human subjects
for compliance with approved departmental guidelines and forward-
ing to IRB for review any activities which are. not within the
approved departmental guidelines.
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Providing further reviews of any such activity for which procedures
involving human subjects are changed, and updating reviews of
activities which continue longer than the approved period (fl 1 year).
3. Reviewing externally funded activities involving human subjects to
assure that the Proposal Transmittal Form is correctly marked with
regard to the use of human subjects.
A. Notifying the IRB of any problems which arise involving human sub-
jects.
5. Assuring that faculty, staff, and students in the department are
well-informed about the policies, procedures and ethical issues in-
volved in the use of human subjects Ln experimentation.
K. Administrative Oversight
The administrative oversight of the Institutional Review Board's
activities is the responsibility of the Vice Chancellor for Research,
who appoints the members of the IRB. The Vice Chancellor keeps informed
about the IRB matters through occasional attendance at IRB meetings and
through the Executive Secretary of the IRB who is on the Vice Chancellor's
staff. The Vice Chancellor reports on the IRB activities at each annual
meeting of the Graduate Faculty.
L. Subject 's Privileges
If a subject or prospective subject wishes to review the UIUC
policies and procedures, he/she may request a copy from the department
executive officer or the Executive Secretary of the Institutional Review
Board, or may review it in the Reference Room of the University Library.
Copies of the UIUC Assurance filed with DHEW are available in the Office
of the Executive Secretary of the Institutional Review Board. One copy
is on file in the University Library Reference Room.
If a subject wishes to voice complaints or concerns regarding
his/her participation in a project, he/she should take the matter to the
executive officer of the department in which the activity is supervised.
The subject may, if not satisfied with the results of that process, refer
his/her concerns to the Executive Secretary of the Institutional Review
Board, who will arrange for the matter to be considered by the Insti-
tutional Review Board.
M. University Provisions to Pro tect Health and Safety of Human
Subjects
The university maintains McKinley Health Center, which includes
a hospital having 58 beds, the usual hospital facilities, and a staff of
physicians. This facility is available for emergencies that may arise
in course of UIUC activities involving human subjects. Arrangements may
*Unit executive officers are responsible for notifying the Institutional
Review Board of any problems which arise involving human subjects.
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be made for physicians from McKinley Health Center or from local
hospitals to monitor work involving human subjects when the Institu-




INSTRUCTIONS FOR USE OF RESEARCH CONSENT FORMS

APPENDIX A
INSTRUCTIONS FOR USE OF RESEARCH CONSENT FORMS*
Adult Consent
1. If space is not adequate for an appropriate "Purpose" or
"Nature of Experiment," place "See attached sheet" in the
space and attach a sheet.
2. Repeat the procedures which are experimental, if they
must also be set out in the "Nature of Experiment" to
make the project understandable.
3. If there are no "Personal Risks," or "Appropriate
Alternative Procedures," simply state that there are
none.
k. Either paragraph A or B should apply. When retyping,
eliminate the one which does not.
5. If further explanation beyond what is written on the
form is required to be sure subject understands the
risk, the witness should hear the explanation and
sign the form.
6. The explanation should be made by the staff member, and
the signature obtained by him personally.
7. Provide the telephone number of the individual who will be
available to answer any future inquiries the subject may have.
8. Provide the subject with a copy of the consent form.
Minor's Consent
1. Your common sense and professional judgment should indicate
when you should ask a minor to sign, and when you should ask
simply for the signature of parents or guardians.
2. Use the minor's consent form for anyone under eighteen years
of age.
3. Where a minor signs his consent, the parents or guardians must
also sign.
Sample Consent Form for Obtaining Blood Samples for Research
1. Although subjects are not necessarily considered to be "at risk"
when project involves venipuncture, the Institutional Review
Board has agreed to require obtaining written informed consent
for these projects.
2. The language of the Sample Form provides an explanation of the
procedure which should be comprehensible to most subjects.
*For further discussion and instructions about the requirements for
obtaining legally effective informed consnet, see Part II pages 5 and 6,
Appendix D, sections U6.9 and U6.10, and Appendix E pages 3 through 5.
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CONSENT FOR PARTICIPATION IN A RESEARCH PROJECT
I, , state that I am over eighteen
(Name of Volunteer)
(l8) years of age and wish to participate in a program of research being
conducted by
.
(Name of Staff Member)
The purpose of the research is:
The project involves
(Nature of Experiment)
The experimental procedures are
The personal risks involved are:
Appropriate alternative procedures which might benefit me personally
are
:
(Strike our A or B)
A) I acknowledge that I have been informed that this procedure is
not intended to benefit my personal health.
B) I acknowledge that I have been informed that this procedure is
also designed to assist in maintaining or improving my personal
health and will benefit me personally in the following way
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I acknowledge that has fully
(Name of Staff Member)
explained to me the risks involved and the need for the research; has
informed me that I may withdraw from participation at anytime; has
offered to answer any inquiries which I may make concerning the procedures
to be followed; and has informed me that I will be given a copy of this
consent form. I freely and voluntarily consent to my participation in
this research project.
(Signature of Volunteer)





MINOR'S CONSENT FOR PARTICIPATION IN A RESEARCH PROJECT
I, , state that I air,
(Name of Volunteer)
years of age and wish to participate in a program of research being
conducted by
.
(Name of Staff Member)
The purpose of the research is:
The project involves
(Nature of Experiment)
The experimental procedures are
The personal risks involved are:
Appropriate alternative procedures which might benefit me personally
are:
I acknowledge that has fully
(Name of Staff Member)
explained to me the risks involved and the need for the research; has informed
me that I may withdraw from participation at anytime; has offered to
answer any inquiries which I may make concerning the procedures to be
followed; and has informed me that I will be given a copy of this con-






We, parents or guardians of the above minor volunteer, agree to the
participation of the above minor in the research project set out above.
V/e have been informed of the need for the research, the benefits to be
derived from it, and the risks involved and that we may withdraw him/her
from participation at any time. We have also been informed that the researcl
can best be conducted with a subject population including minors because of
the nature of the research.
(Strike out A or B)
.
A) Eeing aware of the value of the participation of minors in this
research project and further being aware that this procedure will
not benefit the minor here involved personally, we consent to the
minor's participation.
B) Being aware of the value of the participation of minors in this
research project and being informed that the procedures will also
benefit the above-named minor personally in the following way
we consent to the minor's participation.
Signature of Staff Kember Signature of Parents or Guardian:





CONSENT FOR BLOOD TO BE DRAWN FOR USE IN A RESEARCH PROJECT
I?
, state that I am over eighteen (18)
(Name of Human Subject)
years of age and wish to participate in a program of research being conducted
by
.
(Name of Responsible Project Investigator)
Brief Description of the Project: (Include purpose.)
The experimental procedure for the human subject is to donate
(number)
samples of of blood at intervals of
( # of cc's, # of ounces)
(indicate frequency)
The blood will be drawn by a certified medical technologist, nurse, or other
suitably qualified person.
The personal risks involved are: Slight pain during the drawing of blood and
in rare cases development of what is commonly known as "black and blue mark"
caused by minor seeping of blood around the puncture.
I acknowledge that I have been informed that this procedure is not intended to
benefit my personal health.
I acknowledge that has fully explained
(Responsible Project Investigator)
to me the risks involved and the need for the research, has informed me that I may
withdraw from participation at anytime and has offered to answer any inquiries
which I may make concerning the procedures to be followed. I freely and volun-
tarily consent to my participation in this research project.
(Signature of Human Subject)
(Signature of Responsible Project Investigator)










DEVELOPMENT OF DEPARTMENTAL GUIDELINES FOR THE REVIEW OF ACTIVITIES INVOLVING
HUMAN SUBJECTS .
A large number of activities involving human subjects at no risk beyond those
of ordinary life are undertaken each year without external funding . Some are,
for example, part of introductory and research methods courses; some are short
term pilot projects, doctoral dissertations and independent study projects.
Some are regular faculty research projects. Some involve new use of previously
gathered data on human subjects
.
The large volume of such activities, the fact that for most of these any risks
to the human subjects falls well within the risks of ordinary life, and the
fact that for many the time available for review is extremely short, dictate
that review must be expeditious and simple as well as responsible.
Review of such activities may be handled by the establishment of departmental
guidelines on the basis of the recurring types of "ordinary risk" activities
undertaken by the department and the well established and accepted professional
procedures used in the department. When such departmental guidelines have been
approved by the Institutional Review Board, activities involving human subjects,
which are not externa 1 1 y funded , and which fall within the departmental guidelines,
would not need to be reviewed individually by the IRB.
Departments wishing to use this review mechanism must submit written guidelines
to the IRB which will review them to be sure that the IRB's responsibilities
can be fulfilled.
To be approved by the IRB Departmental Guidelines must:
a) identify the types of activities involving human subjects which are
normally undertaken by the department and with which the department
has had sufficient experience to be able to set standards for appropriate
conduct.
b) define the standards with which such activities would have to comply.
c) assure that the activities fall in Category 1, i.e., involve no risks
exceeding those of ordinary life. (See Part II, Pages 6-10) Note that
activities which involve administration of any drugs or noxious stimuli,
and/or situations which might involve psychological stress are considered
to fall outside the departmental guidelines and therefore require IRB review.
d) assure that the participation of human subjects is voluntary.
e) assure careful attention to the adequacy of protection of the rights,
and welfare of human subjects for the "ordinary" risks that are imposed.
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f) assure the privacy of individuals and small identifiable groups, by-
appropriate procedures and commitments for confidentiality of data.
g) assure consideration of the potential benefit/risk ratio.
h) describe the department's plan for assuring that all projects involving
human subjects which are not sent forward for 1KB review, meet the depart-
mental standards . (Some departments may establish internal review
committees, or assign review responsibility to an individual. Some
departments may rely on careful and continuing instruction and more informal
communication routes.)
i) provide for sufficient documentation so that reports can be made to the
1KB on the department's experience with this decentralized review process.
Note: 1. All externally funded projects or activities involving human
subjects must be reviewed by the Institutional Review Board.
2. Any project or activity involving subjects at risk beyond those
of ordinary life must be submitted for review by the Institutional
Review Board.
3. Any project or activity involving human subjects which does not
fall within the departmental guidelines must be reviewed by the
Institutional Review Board.
k. The Institutional Review Board is available to review any project
or activity upon request. In carrying out its oversight responsibility
the Institutional Review Board may review any UIUC project or activity
involving human subjects, whether or not it falls within departmental
guidelines
.
5. Until departmental guidelines have been developed and approved by
the Institutional Review Board, all projects/activities involving
human subjects must be reviewed by the Institutional Review Board.
APPENDIX C
FORM IRB-1
INFORMATION FOR REVIEW OF ACTIVITY INVOLVING HUMAN SUBJECTS

m IRB-1 Appendix C
Information for Review of Activity involving Human Subjects
(If submitted to IRB for review, submit _L1 copies of this form and
1 copy of proposal for project to be undertaken.)
Name of Responsible Project Investigator Name of Investigator, if different
Title of Project - Purpose
Funding Agency to which submitted,
if any,
5. Grant or Contract Number,
if any,
6. Project Peric
Type of Project 8. Type of Investigator
j | Research D Faculty
j |
Demonstration L 1 Staff
Class Project LTD Graduate Student
| [
Independent [~J~J Undergrad. Student
Study
Q] Other
9. Type of Subject
A. '—' Adult, non-student
1 1 UIUC student
|_J Minor
j 1 Other (explain)
Number of Subjects to be involved
Number of Controls to be involved




i Individual with limite
civil freedom
j




j Pregnant women, fetuse
'—
J newborn, dead
1 1 Project involves use of drugs not certified by
FDA for clinical use for this purpose.
LJ Subjects will receive payment or some form of
compensation for participation.
j |
Access to subjects will be gained through
cooperating institutions.
Written consent form will be obtained.
(Attach copy of form to be used.)
NOTE: All investigators using human subjects should be thoroughly familiar with the
definitions, instructions, policies and procedures described in The Use of Human
Subjects in Research at the University of Illinois - Urbana-Champaign . (Available
from the Executive Secretary, Institutional Review Board, Graduate College.)
Describe the methods to be used for obtaining subjects for this work and for assuring
that their participation is voluntary.
Describe how subjects will be used.
(OVER)
Will the subjects in the proposed work be placed "at risk" as defined in The Use of






5. If the response to item 14 is "No", briefly indicate your reasons for this response.
6. If the response to item 14 is "Yes" or "Uncertain", provide the following information:
(Use additional pages)
a. Describe the possible risks to the subject and the potential benefits to the
subject and/or to others.
b. Describe the method to be used for securing legally effective informed consent
of subjects. Attach copy of the consent form and any oral or written explanation
to be used.
c. Describe the provisions for safeguarding the rights and welfare of the human subje
to be involved in this work, including the provisions for assuring confidentiality
of data and any provisions for medical care or supervision.
Certifications :
I am familiar with The Use of Human Subjects in Research at the University of Illinois
Urbana-Champaign . I subscribe to the standards described therein and will adhere to
the policies and procedures explained therein.
I. Should changes in procedures involving human subjects become advisable, I will submit
them for review prior to initiating the change.
5. If any problems involving human subjects emerge, I will immediately notify the unit







'or optional departmental use:
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SUBTITLE A—DEPARTMENT OF HEALTH,
EDUCATION, AND WELFARE, GENERAL
ADMINISTRATION
PART 46—PROTECTION OF HUMAN
SUBJECTS
Technical Amendments
On May 30, 1974, final regulations
were published in the Federal Register
(39 PR 18914) relating to protection of
human subjects in research, develop-
ment, and related activities supported
by Department of Health, Education,
and Welfare grants and contracts. Short-
ly thereafter, on July 12, 1974, the Na-
tional Research Act, Public Law 93-348,
was enacted. Although the Conference
Report on the bill (H.R. 7724) which
later became Pub. L. 93-348 expressed
satisfaction with the regulations (H. Rep.
No. 93-1148, at p. 26), section 212(a) of
said Law added a new section 474(a) to
the Public Health Service Act, which
provides as follows:
The Secretary shall by regulation require
that each entity which applies for a grant or
contract under this Act for any project or
program which Involves the .conduct of bio-
medical or behavioral research Involving hu-
man subjects submit In or with Its applica-
tion for such grant or contract assurances
satisfactory to the Secretary that It has
established (In accordance with regulations
which the Secretary shall prescribe) a board
(to be known as an 'Institutional Review
Board') to review biomedical and behavioral
research Involving human subjects con-
ducted at or sponsored by such entity in
order to protect the rights of human subjects
of such research.
Section 212(b) of Pub. L. 93-348 fur-
ther stated that the regulations required
to carry out section 474(a) shall apply
with respect to applications for grants
and contracts under the Public Health
Service Act submitted after promulgation
of such regulations.
The regulations published on May 30,
1974, codified at 45 CFR Part 46, would
with minor, technical changes fully Im-
plement section 474(a). This would be
accomplished by: (1) amending the cita-
tion of AUTHORITY to refer to section
474(a) , (2) substituting references to
"institutions" and "Institutional Review
Boards" for existing references to "or-
ganizations" and "committees" and mak-
ing related changes, and (3) revising 45
CFR 46.7, 46.11(a), and 46.12 to take
account of the requirement in section 474
(a) that an assurance concerning estab-
lishment of a Board must in all cases be
submitted in or with the application.
Since Part 46 was published initially as a
notice of proposed rulemaking (38 FR
27882), and since the aforesaid changes
would be minor and technical in nature,
it is unnecessary to publish such changes
as a notice of proposed rulemaking. The
Department therefore finds that good
cause exists for dispensing with this step.
Accordingly, the regulations published
in the Federal Register on May 30, 1974
and codified at 45 CFR Part 46, as so
amended, are hereby adopted as final
regulations implementing section 474(a)
RULES AND REGULATIONS
of the Public Health Service Act, ef-
fective March 13, 1975.




Approved: March 7, 1975.
Caspar W. Weinberger,
Secretary.
Therefore, Subtitle A of Title 45 of the
Code of Federal Regulations is amended













Minimum requirements for general
assurances.
46.7 Minimum requirements for special
assurances.
46.8 Evaluation and disposition of assur-
ances.
46.9 Obligation to obtain Informed con-.
sent; prohibition of exculpatory
clauses.
46 10 Documentation of Informed consent.
46.11 Submission and certification of appli-
cations and proposals, general as-
surances.
46 12 Submission and certification of appli-
cations and proposals, special assur-
ances.
46.13 Applications and proposals lacking
definite plans for involvement of
human subjects.
46.14 Applications and proposals submitted
with the Intent of not Involving
human subjects.
46.16 Evaluation and disposition of applica-
tions and proposals.
46.16 Cooperative activities.
46.17 Investigational new drug 30-day delay
requirement.
46.18 Institution's executive responsibility.
46.19 Institution's records; confidentiality.
46.20 Reports.
46 21 Early termination of awards; evalua-
tion of subsequent applications and
proposals.
46.22 Conditions.
Authority: 5 U.S.C. 301; sec. 474(a), 88
Stat. 362 (42 U.S.C. 2891-3(a) ).
§ 46.1 Applicability.
(a) The regulations in this part are
applicable to all Department of Health,
Education, and Welfare grants and con-
tracts supporting research, development,
and related activities in which human
subjects are involved.
(b) The Secretary may, from time to
time, determine in advance whether
specific programs, methods, or proce-
dures to which this part is applicable
place subjects at risk, as defined in
§46.3(b). Such determinations will be
published as notices in the Federal Reg-
ister and will be included in an appendix
to this part.
§ 46.2 Policy.
(a) Safeguarding the rights and wel-
fare of subjects at risk in activities sup-
ported under grants and contracts from
DHEW is primarily the responsibility of
the institution which receives or is ac-
accountable to DHEW for the funds
awarded for the support of the activity.
In order to provide for the adequate
discharge of this institutional respon-
sibility, it is the policy of DHEW that
no activity involving human subjects to
be supported by DHEW grants or con-
tracts shall be undertaken unless an In-
stitutional Review Board has reviewed
and approved such activity, and the in-
stitution has submitted to DHEW a cer-
tification of such review and approval,
in accordance with the requirements of
this part.
(b) This review shall determine wheth-
er these subjects will be placed at risk,
and, if risk is involved, whether:
(1) The risks to the subject are so out-
weighed by the sum of the benefit to the
subject and the importance of the knowl-
edge to be gained as to warrant a deci-
sion to allow the subject to accept these
risks;
(2) the rights and welfare of any such
subjects will be adequately protected;
(3) legally effective informed consent
will be obtained by adequate and appro-
priate methods in accordance with the
provisions of this part ; and
(4) the conduct of the activity will be
reviewed at timely intervals.
(c) No grant or contract involving
human subjects at risk shall be made to
an individual unless he is affiliated with
or sponsored by an institution which can
and does assume responsibility for the
subjects involved.
§ 46.3 Definitions.
(a) "Institution" means any public or
private institution or agency (including
Federal, State, and local government
agencies)
.
(b) "Subject at risk" means any in-
dividual who may be exposed to the pos-
sibility of injury, including physical,
psychological, or social injury, as a con-
sequence of participation as a subject in
any research, development, or related ac-
tivity which departs from the application
of those established and accepted meth-
ods necessary to meet his needs, or which
increases the ordinary risks of daily life.
Including the recognized risks inherent
in a chosen occupation or field of service.
(c) "Informed consent" means the
knowing consent of an individual or his
legally authorized representative, so sit-
uated as to be able to exercise free power
of choice without undue inducement or
any element of force, fraud, deceit, du-
ress, or other form of constraint or coer-
cion. The basic elements of information
necessary to such consent include
:
(1) A fair explanation of the proce-
dures to be followed, and their purposes,
Including Identification of any proce-
dures which are experimental;
(2) a description of any attendant dis-
comforts and risks reasonably to be ex-
pected;
(3) a description of any benefits rea-
sonably to be expected;
(4) a disclosure of any appropriate al-
ternative procedures that might be ad-
vantageous for the subject;
(5) an offer to answer any inquiries
concerning the procedures; and
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(6) an instruction that the person is
free to withdraw his consent and to dis-
continue participation in the project or
activity at any time without prejudice to
the subject.
(d) "Secretary" means the Secretary
of Health, Education, and Welfare or
any other officer or employee of the De-
partment of Health, Education, and Wel-
fare to whom authority has been dele-
gated.
(e) "DHEW" means the Department
of Health, Education, and Welfare.
(f) "Approved assurance" means a
document that fulfills the requirements
of this part and is approved by the Sec-
retary.
(g> "Certification"' means the official
institutional notification to DHEW in ac-
cordance with the requirements of this
part that a project or activity involving
human subjects at risk has been reviewed
and approved by the institution in ac-
cordance with the "approved assurance"
on file at DHEW.
(h) "Legally authorized representa-
tive" means an individual or judicial or
other body authorized under applicable
law to consent on behalf of a prospective
subject to such subject's participation in
the particular activity or procedure.
§ 46.4 Submission of assurances.
(a) Recipients or prospective recip-
ients of DHEW support under a grant
or contract involving subjects at risk
shall provide written assurance accepta-
ble to DHEW that they will comply with
DHEW policy as set forth in this part.
Each assurance shall embody a state-
ment of compliance with DHEW require-
ments for initial and continuing Institu-
tional Review Board review of the sup-
ported activities; a set of implementing
guidelines, including identification of the
Board and a description of its review pro-
cedures; or, in the case of special as-
surances concerned with single activi-
ties or projects, a report of initial findings
of the Board and of its proposed continu-
ing review procedures.
(b) Such assurance shall be executed
by an individual authorized to act for the
institution and to assume on behalf of
the institution the obligations imposed by
this part, and shall be filed in such form
and manner as the Secretary may re-
quire.
§ 46.5 Types of assurances.
(a) General assurances. A general as-
surance describes the review and imple-
v
mentation procedures applicable to all
DHEW-supported activities conducted by
an institution regardless of the number,
location, or types of its components or
field activities. General assurances will
be required from institutions having a
significant number of concurrent DHEW-
supported projects or activities involving
human subjects.
(b) Special assurances. A special as-
surance will, as a rule, describe those
review and implementation procedures
applicable to a single activity or project.
A special assurance will not be solicited
or accepted from an institution which
has on file with DHEW an approved
general assurance.
V
§ 46.6 * Minimum requirements for gen-
eral assurances.
General assurances shall be submitted
in such form and manner as the Secre-
tary may require. The institution must
include, as part of its general assurance,
implementing guidelines that specifically
provide for:
(a) A statement of principles which
will govern the institution in the dis-
charge of its responsibilities for protect-
ing the rights and welfare of subjects.
This may include appropriate existing
codes or declarations, or statements for-
mulated by the institution itself. It is to
be understood that no such principles
supersede DHEW policy or applicable
law.
(b> An Institutional Review Board or
Board structure which will conduct ini-
tial and continuing reviews in accord-
ance with the policy outlined in § 46.2.
Such Board structure or Board shall
meet the following requirements:
» 1 ) The Board must be composed of
not less than five persons with varying
backgrounds to assure complete and ade-
quate review of activities commonly con-
ducted by the institution. The Board
must be sufficiently qualified through the
maturity, experience, and expertise of
its members and diversity of its member-
ship to insure respect for its advice and
counsel for safeguarding the rights and
welfare of human subjects. In addition
to possessing the professional compe-
tence necessary to review specific activi-
ties, the Board must be able to ascertain
the acceptability of applications and pro-
posals in terms of institutional commit-
ments and regulations, applicable law,
standards of professional conduct and
practice, and community attitudes. The
Board must therefore include persons
whose concerns are in these areas.
(2*) The Board members shall be iden-
tified to DHEW by name; earned degrees,
if any; position or occupation; represent-
ative capacity; and by other pertinent
indications of experience such as board
certification, licenses, etc., sufficient to
describe each member's chief anticipated
contributions to Board deliberations. Any
employment or other relationship be-
tween each member and the Institution
shall be identified, i.e., full-time em-
ployee, part-time employee, member of
governing panel or board, paid consult-
ant, unpaid consultant. Changes in Board
membership shall be reported to DHEW
in such form and at such times as the
Secretary may require.
-. (3) No member of a Board shall be
involved in either the initial or continu-
ing review of an activity in which he has
a conflicting interest, except to provide
information requested by the Board.
(4) No Board shall consist entirely of
persons who are officers, employees, or
agents, of, or are otherwise associated
with the institution, apart from their
membership on the Board.
• 5) No Board shall consist entirely of
members of a single professional group.
• .. (6) The quorum of the Board shall be
defined, but may in no event be less than
a majority of the total membership duly
convened to carry out the Board's re-
sponsibilities under the terms of the as-
surance. /
(c) Procedures which the institution
will follow in its initial and continuing
review of applications, proposals, and
activities.
fd) Procedures which the Board will
follow (1) to provide advice and counsel
to activity directors and investigators
with regard to the Board's actions. (2)
to insure prompt reporting to the Board
of proposed changes in an activity and of
unanticipated problems involving risk to
subjects or others, and (3> to insure that
any such problems, including adverse re-
actions to biologicals, dnigs. radioisotope
labelled drugs, or to medical devices, are
promptly reported to DHEW.
<e> Procedures which the institution
will follow to maintain an active and
effective Board and to implement its
recommendations.
§ 16.7 Minimum requirements for spe-
cial assurances.
Special assurances shall be submitted
in such form and manner as the Secre-
tary may require. An acceptable special
assurance shall
:
(a) Identify the specific grant or con-
tract involved by its full title; and by
the name ot the activity or project di-
rector, principal investigator, fellow, or
other person immediately responsible for
the conduct of the activity.
(b) Include a statement, executed by
an appropriate institutional official, in-
dicating that the institution has estab-
lished an Institutional Review Board
satisfying the requirements of § 46.6(b).
(c) Describe the makeup of the Board
and the training, experience, and back-
ground of its members, as required by
§ 46.6(b) (2).
(d) Describe in general terms the risks
to subjects that the Board recognizes as
inherent in the activity, and justify its
decision that these risks are so out-
weighed by the sum of the benefit to the
subject and the importance of the knowl-
edge to be gained as to warrant the
Board's decision to permit the subject
to accept these risks.
<e) Describe the informed consent
procedures to be used and attach docu-
mentation as required by § 46.10.
(f) Describe procedures which the
Board will follow to insure prompt re-
porting to the Board of proposed.changes
in the activity and of any unanticipated
problems, involving risks to subjects or
others and to insure that any such prob-
lems, including adverse reactions to
biologicals, drugs, radioisotope labelled
drugs, or to medical devices are promptly
reported to DHEW.
(g) Indicate at what time intervals
the Board will meet to provide for con-
tinuing review. Such review must occur
no less than annually.
(h> Be signed by the individual mem-
bers of the Board and be endorsed by an
appropriate institutional official.
§ 46.8 Evaluation and disposition of as-
surances.
(a) All assurances submitted in ac-
cordance with 5§ 46.6 and 46.7 shall be
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evaluated by the Secretary through such
officers and employees of DHEW and
such experts or consultants engaged for
this purpose as he determines to be ap-
propriate. The Secretary's evaluation
shall take Into consideration, among
other pertinent factors, the adequacy
of the proposed Institutional Review
Board in the light of the anticipated
scope of the applicant institution's ac-
tivities and the types of subject popula-
tions likely to be involved, the appro-
priateness of the proposed initial and
continuing review procedures In the
light of the probable risks, and the size
and complexity of the institution.
(b) On the basis of his evaluation of
an assurance pursuant to paragraph (a)
of this section, the Secretary shall (1)
approve, (2) enter into negotiations to
develop a more satisfactory assurance,
or (3) disapprove. With respect to ap-
proved assurances, the Secretary may
determine the period during which any
particular assurance or class of assur-
ances shall remain effective or otherwise
condition or restrict his approval. With
respect to negotiations, the Secretary
may, pending completion of negotiations
for a general assurance, require an in-
stitution otherwise eligible for such an
assurance, to submit special assurances.
§ 46.9 Obligation to obtain informed
consent; prohibition of cvculpalory
clauses.
Any Institution proposing to place any
subject at risk is obligated to obtain and
document legally effective informed con-
sent. No such informed consent, oral or
written, obtained under an assurance
provided pursuant to this part shall in-
clude any exculpatory language through
which the subject is made to waive, or to
appear to waive, any of his legal rights,
including any release of the institution
or Its agents from liability for negli-
fence.
§ 46.10 Documentation of informed
consent.
The actual procedure utilized in ob-
taining legally effective informed con-
sent and the basis for Institutional Re-
view Board determinations that the pro-
cedures are adequate and appropriate
shall be fully documented. The docu-
mentation of consent will employ one of
the following three forms:
(a) Provision of a written consent
document embodying all of the basic ele-
ments of Informed consent. This may be
read to the subject or to his legally au-
thorized representative, but in any event
he or his legally authorized representa-
tive must be given adequate opportunity
to read it. This document is to be signed
by th* subject or his legally authorized
representative. Sample copies of the
consent form as approved by the Board
are to be retained in Its records.
(b) Provision of a "short form" writ-
ten consent document indicating that
the basic elements of Informed consent
have been presented orally to the sub-
ject or his legally authorized representa-
tive. Written summaries of what Is to be
said to the patient are to be approved by
the Board. The short form Is to be signed
by the subject or his legally authorized
representative and by an auditor witness
to the oral presentation and to the sub-
ject's signature. A copy of the approved
summary, annotated to show any addi-
tions, is to be signed by the persons
officially obtaining the consent and by
the auditor witness. Sample copies of the
consent form and of the summaries as
approved by the Board are to be retained
in its records.
<c) Modification of either of the pri-
mary procedures outlined in paragraphs
(a) and (b) of this section. Granting of
permission to use modified procedures
imposes additional responsibility upon
the Board and the institution to estab-
lish: (D that the risk to any subject is
minimal, (2) that use of either of the
primary procedures for obtaining in-
formed consent would surely invalidate
objectives of considerable immediate im-
portance, and (3 1 that any reasonable
alternative means for attaining these ob-
jectives would be less advantageous to
the subjects. The Board's reasons for
permitting the use of modified proce-
dures must be individually and specifi-
cally documented in the minutes and in
reports of Board actions to the files of
the institution. All such modifications
should be regularly reconsidered as a
function of continuing review and as re-
quired for annual review, with documen-
tation of reaffirmation, revision, or dis-
continuation, as appropriate.
§46.11 Submission and certification of
applications and proposals, general
assurances.
(a) Timely review. Any institution
having an approved general assurance
shall indicate in each application or pro-
posal for support of activities covered
by this part (or in a separate document
submitted with such application or pro-
posal) that it has on file with DHEW
such an assurance. In addition, unless
the Secretary otherwise provides, each
such application or proposal must be
given review and, when found to involve
subjects at risk, approval, prior to sub-
mission to DHEW. In the event the Sec-
retary provides for the performance of
institutional review of an application or
proposal after its submission to DHEW,
processing of such application or pro-
posal by DHEW will under no circum-
stances be completed until such institu-
tional review and approval has been
certified. Except where the institution de-
termines that human subjects are not in-
volved, the application or proposal
should be appropriately certified In the
spaces provided on forms, or one of the
following certifications, as appropriate,
should be typed on the lower or right
hand margin of the page bearing the
name of an official authorized to sign or
execute applications or proposals for the
Institution.
Human Subjects: Reviewed, Not at Risk.
(Date)
Human Subjects: Reviewed, At Risk, Ap-
proved
(Date)
(b> Applications and proposals not cer-
tified. Applications and proposals not
properly certified, or submitted as not in-
volving human subjects and found by the
operating agency to involve human sub-
jects, will be returned to the institution
concerned.
§ 46.12 Submission and certification of
applications and proposals, special
assurances.
(a) Except as provided in paragraph
(b) of this section, institutions not hav-
ing an approved general assurance shall
submit in or with each application or
proposal for support of activities covered
by this part a separate special assurance
and certification of its review and ap-
proval.
(b) If the Secretary so provides, the
assurance which must be submitted in or
with the application or proposal under
paragraph <a> of this section need sat-
isfy only the requirements of §46.7(a>
and § 46.7(b) of this part. Under such
circumstances, processing of such ap-
plication or proposal by DHEW will not
be completed until a further assurance
satisfying the remaining requirements
of 8 46.7 has been submitted to DHEW
(c) An assurance and certification pre-
pared in accordance with this part and
approved by DHEW shall be considered
to have met the requirement for cer-
tification for the initial grant or contract
period concerned. If the terms of the
grant or contract recommend additional
support periods, each application or pro-
posal for continuation or renewal of sup-
port must satisfy the requirements of
this section or 5 46.11 whichever Is ap-
plicable at the time of its submission.
§ 46.13 Applications and proposals lack-
ing definite plans for involvement of
human subjects.
Certain types of applications or pro-
posals are submitted with the knowledge
that subjects are to be Involved within
the support period, but definite plans for
this involvement would not normally be
set forth in the application or proposal.
These include such activities as (a) in-
stitutional type grants where selection of
projects is the responsibility of the in-
stitution, (b) training grants where
training projects remain to be selected,
and (c) research, pilot, or developmental
studies in which involvement depends
upon such things as the completion of
instruments, or of prior animal studies,
or upon the purification of compounds.
Such applications or proposals shall be
reviewed and certified in the same man-
ner as more definitive applications or
proposals. The initial certification indi-
cates institutional approval of the ap-
plications or proposals as submitted, and
commits the institution to later review
of the plans when completed. Such later
review and certification to DHEW should
be completed prior to the beginning of
the budget period during which actual
involvement of human subjects is to be-
gin. Review and certification to DHEW
must in any event be completed prior
to involvement of human subjects.
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§ 46.14 Applications and proposals sub-
mitted with the intent of not involv-
ing human subject".
If an application or proposal does not
anticipate involving or intend to involve
human subjects, no certification should
be included with the initial submission
of the application or proposal. In those
instances, however, when later it be-
comes appropriate to use all or part of
awarded funds for one or more activities
which will involve subjects, each such
activity shall be reviewed and approved
In accordance with the assurance of the
institution prior to the involvement of
subjects. In addition, no such activity
shall be undertaken until the institution
has submitted to DHEW : (a) a certifica-
tion that the activity has been reviewed
and approved in accordance with this
part, and (b) a detailed description of
the proposed activity (including any pro-
tocol or similar document) . Also, where
support Is provided by project grants or
contracts, subjects shall not be involved
prior to certification and institutional re-
ceipt of DHEW approval and, in the case
of contracts, prior to negotiation and
approval of an amended contract de-
scription of work.
§ 46.15 Evaluation and disposition of
applications and proposals.
(a) Notwithstanding any prior review,
approval, and certification by the insti-
tution all applications or proposals in-
volving human subjects at risk submitted
to DHEW shall be evaluated by the Sec-
retary for compliance with this part
through such officers and employees of
the Department and such experts or con-
sultants engaged for this purpose as he
determines to be appropriate. This eval-
uation may take into account, among
other pertinent factors, the apparent
risks to the subjects, the adequacy of
protection against these risks, the poten-
tial benefits of the activity to the sub-
jects and to others, and the importance
of the knowledge to be gained.
(b) Disposition. On the basis of his
svaluation of an application or proposal
pursuant to paragraph (a) of this section
^nd subject to such approval or recom-
mendation by or consultation with ap-
propriate councils, committees, or other
bodies as may be required by law, the
Secretary shall (1) approve, (2) defer
tor further evaluation, or (3) disapprove
support of the proposed activity in whole
Dr in part. With respect to any approved
grant or contract, the Secretary may im-
pose conditions, including restrictions on
the use of certain procedures, or certain
subject groups, or requiring use of spec-
ified safeguard* or informed consent pro-
cedures when in his judgment such con-
dition.; are necessary for the protection
of human subjects.
§ 46.16 Cooperative activities.
Cooperative activities are those which
Involve institutions in addition to the
grantee or prime contractor (such as a
contractor under a grantee or a subcon-
tractor under a prime contractor) . If, in
such instances, the grantee or prime con-
tractor obtains access to ail or some of
the subjects involved through one or
more cooperating institutions, the basic
DHEW policy applies and the grantee
or prime contractor remains responsible
for safeguarding the rights and welfare
of the subjects.
(a) Institution with approved general
assurance. Initial and continuing review
by the institution may be carried out by
one or a combination of procedures:
(1) Cooperating institution with ap-
proved general assurance. When the co-
operating institution has on file with
DHEW an approved general assurance,
the grantee or contractor may, in addi-
tion to its own review, request the co-
operating institution to conduct an in-
dependent review and to report its
recommendations on those aspects of the
activity that concern individuals for
whom the cooperating institution has re-
sponsibility under its own assurance to
the grantee's or contractor's Institutional
Review Board. The grantee or contractor
may, at its discretion, concur with or
further restrict the recommendations of
the cooperating institution. It is the re-
sponsibility of the grantee or contractor
to maintain communication with the
Boards of the cooperating institution.
However, the cooperating institution
shall promptly notify the grantee or con-
tracting institution whenever the co-
operating institution finds the conduct
of the project or activity within its pur-
view unsatisfactory.
(2) Cooperating institution with no
approved general assurance. When the
cooperating institution does not have an
approved general assurance on file with
DHEW, the DHEW may require the sub-
mission of a general or special assurance
which, if approved, will permit the
grantee or contractor to follow the pro-
cedure outlined in the preceding sub-
paragraph.
(3 1 Intel-institutional joint review. The
grantee or contracting institution may
wish to develop an agreement with co-
operating institutions to provide for an
Institutional Review Board with repre-
sentatives from cooperating institutions.
Representatives of cooperating institu-
tions may be appointed as ad hoc mem-
bers of the grantee or contracting in-
stitution's existing Institutional Review
Board or, if cooperation is on a frequent
or continuing basis as between a medical
school and a group of affiliated hospitals,
appointments for ext*»vled periods may
be made. All such cooperative arrange-
ments must be approved by DHEW as
part of a general assurance, or as an
amendment to a general assurance.
(b) Institutions with special assur-
ances. While responsibility for initial and
continuing review necessarily lies with
the grantee or contracting institution,
DHEW may also require approved as-
surances from those cooperating institu-
tions having immediate responsibility for
subjects.
If the cooperating institution has on
file with DHEW an approved general as-
surance, the grantee or contractor shall
request the cooperating institution to
conduct its own independent review of
those aspects of the project or activity
which will involve human subjects for
which it has responsibility. Such a re-
quest shall be in writing and should pro-
vide for direct notification of the grant-
ee's or contractor's Institutional Review-
Board in the event that the cooperating
institution's Board finds the conduct of
the activity to be unsatisfactory. If the
cooperating institution does not have an
approved general assurance on file with
DHEW, it must submit to DHEW a gen-
eral or special assurance which is deter-
mined by DHEW to comply with the pro-
visions of this part.
§ 46.17 Investigational nc» drug 30-day
delay requirement.
Where an institution is required to pre-
pare or to submit a certification under
§§46.11, 46.12, 46.13, or 46.14 and the
application or proposal involves an in-
vestigational new drug within the mean-
ing of The Food, Drug, and Cosmetic Act,
the drug shall be identified in the cer-
tification together with a statement that
the 30-day delay required by 21 CFR
312.1(a)(2) has elapsed and the Food
and Drug Administration has not, prior
to expiration of such 30-day interval, re-
quested that the sponsor continue to
withhold or to restrict use of the drug
in human subjects; or that the Food and
Drug Administration has waived the 30-
day delay requirement; provided, how-
ever, that in those cases in which the 30-
day delay interval has neither expired
nor been waived, a statement shall be
forwarded to DHEW upon such expira-
tion or upon receipt of a waiver. No cer-
tification shall be considered acceptable
until such statement has been received.
§ 46.18 Institution's executive responsi-
bility.
Specific executive functions to be con-
ducted by the institution include policy
development and promulgation and con-
tinuing indoctrination of personnel. Ap-
propriate administrative assistance and
support shall be provided for the Board's
functions. Implementation of the Board's
recommendations through appropriate
administrative action and followup is a
condition of DHEW approval of an assur-
ance. Board approvals, favorable actions,
and recommendations are subject to re-
view and to disapproval or further re-
striction by the institution officials. Board
disapprovals, restrictions, or conditions
cannot be rescinded or removed except by
action of a Board described in the assur-
ance approved by DHEW.
§ 46.19 Institution's records; confiden-
tiality.
(ai Copies of all documents presented
or required for initial and continuing
review by the Institutional Review Board,
such as Board minutes, records of sub-
ject's consent, transmittals on actions,
instructions, and conditions resulting
from Board deliberations addressed to
the activity director, are to be retained
by the institution, subject to the terms
and conditions of grant and contract
awards.
(b) Except as otherwise provided by
law information in the records or pos-
session of an Institution acquired in con-
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nection with an activity covered by this
part, which information refers to or can
be identified with a particular subject,
may not be disclosed except:
(1) with the consent of the subject or
his legally authorized representative; or
(2) as may be necessary for the Sec-
retary to carry out his responsibil^^
under this part.
§ 46.20 Reporls.
Each institution with an approved as-
surance shall provide the Secretary with
such reports and other information as
the Secretary may from time to time
prescribe.
§46.21 Early termination of awards;
evaluation of subsequent applications
and proposals.
(a) If, In the judgment of the Secre-
tary an institution has failed materially
to comply with the terms of this policy
with respect to a particular DHEW grant
or contract, he may require that said
grant or contract be terminated or sus-
pended in the manner prescribed in ap-
plicable grant or procurement regula-
tions.
<b) In evaluating applications or pro-
posals for support of activities covered
by this part, the Secretary may take into
account, in addition to ail other eligibil-
ity requirements and program criteria,
such factors as: (1) whether the appli-
cant or offeror has been subject to a
termination or suspension under para-
graph (a) of this section, (2) whether
the applicant or offeror or the person
who would direct the scientific and tech-
nical aspects of an activity has in the
judgment of the Secretary failed mate-
rially to discharge his, her, or its respon-
sibility for the protection of the rights
and welfare of subjects in his, her, or its
care (whether or not DHEW funds were
involved), and (3) whether, where past
deficiencies have existed in discharging
such responsibility, adequate steps have
in the judgment of the Secretary been
taken to eliminate these deficiencies.
§ 46.22 Conditions.
The Secretary may with respect to any
grant or contract or any class of grants
or contracts impose additional conditions
prior to or at the time of any award
when in his judgment such conditions
are necessary for the protection of
human subjects.
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SUBTITLE A—DEPARTMENT OF HEALTH,
EDUCATION, AND WELFARE
pART 46—PROTECTION OF HUMAN
SUBJECTS
Fetuses, Pregnant Women, In Vitro
Fertilization
Basic regulations governing the pro-
tection of human subjects involved in
research development, and related ac-
tivities supported or conducted by the
Department through grants and con-
tracts were published in the Federal
Register on May 30, 1974 (39 FR 18914) .'
At that time it was indicated that no-
tices of proposed rulemaking would be
developed to provide additional protec-
tion for subjects of research who may
have diminished capacity to provide in-
formed consent. On August 23, 1974, a
notice of proposed rulemaking was pub-
lished for public comment (39 FR 30648)
in which it was proposed to amend 45
CFR Part 46 to provide further protective
measures for the fetus, the abortus,
prisoners, and the institutionalized men-
tally disabled as subjects of research ac-
tivities.
On July 12, 1974, the National Re-
search Act (Pub. L. 93-348) was signed
into law, thereby creating the National
Commission for the Protection of Human
Subjects of Biomedical and Behavioral
Research. One of the charges to the Com-
mission was to investigate and study the
nature and extent of research involving
the living human fetus and to recom-
mend to the Secretary the circumstances
(if any) under which such research
should be conducted or supported by the
Department. Pursuant to section 202(b)
of that Act, the Commission has trans-
mitted Recommendations to the Secre-
tary. Pursuant to section 205 of the Act,
the Secretary is publishing that Report
elsewhere in this issue of the Federal
Register.
After considering both the pubic
comments to the proposed rulemaking
published August 23, 1974, and the Rec-
ommendations of the Commission, the
Secretary has determined to amend 45
CFR 46 by adding a subpart governing
research involving the fetus, the preg-
nant woman, and products of human in
vitro fertilization consistent with the
public comments and the Recommenda-
tions of the Commission. This amend-
ment to the regulations is to be effective
immediately . The Secretary, as required
by Pub. L. 93-348, section 205, will take
into consideration any comments sub-
mitted regarding the Recommendations
and, if it appears necessary, will pro-
pose further rulemaking with respect to
any amendments to these regulations
which appear warranted.
The Secretary also concludes that the
moratorium on fetal research which was
"imposed" by the Department on August
27, 1974 (39 FR 30962) may now he lifted
allowing research to go forward under
the regulations issued herewith. The Sec-
1 These were readopted with minor tech-
nical amendments in the Federal Recisteb
for March 13. 1976 (40 FR 1 1854)
.
retary notes in this regard that the re-
strictions imposed by section 213 of the
National Research Act (Pub. L. 93-348)
extended only until the Commission had
submitted its Recommendations to the
Secretary on May 21, 1975.
Over 125 individuals commented on
subpart C (here stated as subpart B) of
the proposed rulemaking which pertains
to the fetus, the abortus, the pregnant
woman, and the products of human in
vitro fertilization. Those comments, and
the Recommendations of the Commis-
sion, are summarized as follows:
Applicability. Commenters objected to
the applicability of this subpart to "ac-
tivities involving women who could be-
come pregnant, except where the appli-
cant or offeror shows to the satisfaction
of the Secretary that adequate steps will
be taken to avoid involvement of women
who are pregnant." Concern was ex-
pressed that implementation of such a
provisions might involve numerous preg-
nancy tests during the course of an in-
vestigation, and still not achieve this
goal. The Department notes that al-
though the Commission expressed con-
cern that the fetus not be involvecL
m-iintpntionally in research activities^
"did not make a specific rWUllllliUhUalion
with respect to this. The Department
concludes that the Institutional Review
Boards should determine whether ade-
quate measures will be taken to avoid
unintentional involvement of pregnant
women in research activities which are
not designed to include pregnant women
or the fetus and which might present a
risk to a fetus if such existed. Section
46.102(b) (5) of subpart A is therefore
amended to add such determinations as
one of the duties of the Institutional Re-
view Board.
The notice published August 23, 1974,
was limited to biomedical research. That
limitation has been removed because,
while the Department believes that this
subpart applies primarily to biomedical
research, other research may be pro-
posed which might fall under the scope
1 of this subpart.
Definitions. The Department has re-
viewed with care the definitions adopted
by the Commission, and determined that
those definitions should be Incorporated
substantially as drafted into the regula-
tions. It should be noted that in so doing,
the Department has extended the mean-
ing of the term "fetus" to include the
fetus ex utero until such time as such a
fetus is determined to be viable. The
effect of this change is to delete the
term "abortus" which appeared in the
proposed rulemaking, and refer instead
to a fetus ex utero. The Department
agrees with the Commission that such
usage serves the interests of both con-
sistency and clarity, although it may
vary at times from legal, medical, or
common usage. Also, consistent with the
(determination discussed above, the defi-
nition of "biomedical research" has been
dropped.
Ethical advisory boards. A number of
respondents expressed concern that an
Ethical Advisory Board, as proposed,
would be overburdened and would add an
unnecessary layer to a review process
which is already time consuming. It was
also suggested that the Institutional Re-
view Boards can, and in many Instances
already do, perform at the local level
many of the tasks suggested for the
Board. On the other hand, some respond-
ents endorsed the proposal as a welcome
measure to insure that projects would ou
stringently reviewed at a national level
for ethical considerations prior to re-
ceiving support with public monies.
The Commission recommended that •;
national review body I similar to that pro •
posed by the Department) consider the
ethical problems raised by research pro-
posals to which the application of slnnr* •
ards enumerated in their recommenda-
tions proves difficult.
' The Department has considered tht_.-c
suggestions and agrees that whereas the
Institutional Review Boards may be able
to assume a large share of the ethical
review of proposals, it is also true that
there will be instances in which the ap-
plication of standards to specific cases
will be difficult or in which review at the
national level is desirable. The Depart-
ment therefore has determined that such
an Ethical Advisory Board is necessaiy
to assure that projects supported or con-
ducted by the Department meet ethical
standards acceptable to the general com-
munity. However, because the nature oi
the activities may be different and the
number of activities requiring review
may be large, one Board will be estab-
lished to provide advice to the Public
Health Service and one Board will be
established to provide advice to other
components of the Department, with re-
spect to policy governing certain kind.;
of research, and also with respect to the
funding of individual proposals which
raise ethical problems. While the Boards
will propose to the Secretary categoiies
of research which the Board believes
either require or do not require their
review, research protocols and proce-
dures which involve minimal or no risk,
and which clearly conform to the re-
quirements of this subpart, generally
need not be reviewed by the Ethical Ad-
visory Board. Research proposals whicli
are judged by agency advisors or staff
to require further evaluation of risk or
the interpretation of the requirement -
the Secretary unless the Ethical Advisory
Board, or which raise ethical problems,
may not be conducted or supported by
the Secretary unless the Ethical Advisory
Board has reviewed and rendered its ad-
vice concerning the research activity. It
is intended, ultimately, that a similar ac-
quirement for Board review be extended
to other classes of research subjects.
A number of comments were received
regarding the composition of the Ethi-
cal Advisory Board, its duties, or the
manner in which it should conduct il^
meetings. Specifically, the Commission
recommended that women and minori-
ties be adequately represented on ihe
Board, and that its deliberations be con-
ducted with full public participation.
Many of the suggestions are currently
incorporated in regulations governing
Federal committee membership and ac-
tivities. Others will be addressed in the
Charter of the Board which the Secre-
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tary will publish In the Federal Register
at a later date.
Establishment of a consent commit-
tee. Although there was general agree-
ment among commenters that provisions
should be made to monitor conditions
surrounding the consent process, there
was criticism of the proposal to create
separate committees to perform this
function. For the most part, It was felt
that the Institutional Review Boards
could and should perform tills function
as part of continuing responsibility for
the protection of human subjects. It was
further suggested that additional panels
should not be created unless the De-
partment has evidence that the neces-
sary functions could not be performed
by the Institutional Review Boards or
other existing committees.
The Commission noted that it will be
undertaking a study, as part of its man-
date under Pub. L. 93-348, of the effec-
tiveness of Institutional Review Boards
in implementing DHEW regulations for
the protection of human subjects. It
recommended that until the study is
completed, the responsibility for moni-
toring the consent process should be as-
sumed by the Institutional Review
Boards. The Department agrees. The
provisions for creating Consent Commit-
tees nave tnereiore pcerTcleleted, and the
fluties ijplpr^p^ [fl rnem n] j np proposed
JUtoaflJttog rinvn hnnn nivrm tn riif ffisti ~
factional fifvipw Hoards This is reflected
in § 46.205. titled "Additional duties of
the Institutional Review Boards in con-
nection with activities involving fetuses,
pregnant women, or Iranian in vitro
fertilization."
The Department received a number
of criticisms regarding the provision that
the Consent Committee be authorized
to terminate the participation of sub -
jgctTy'ifrlPUl Uiyif L'fln.sejaL, I § Id BBS ' a '
(2) ol the proposed rulemaking)
. It was
argued that this would be an unwar-
ranted infringement of an individual's
right to consent. The Department agrees,
and snnh a.»|hnrl1-.v has hf>en deleted.
Research involving in vuro'Te'mliza-
tion. Commenters generally endorsed
the Department's proposal not to reg-
ulate research involving human in vitro
fertilization other than to require that
all proposals involving such research be
reviewed for approval by the Ethical
Advisory Board. The Commission did 1
not make any recommendation concern-
ing this category of research in the re-
port submitted on May 21. The Depart-
ment therefore makes no change from
the proposed rulemaking with respect to
research involving in vitro fertilization.
The requirement that all such propo-
sals be reviewed by the Ethical Advisory
Board, as well as by the Institutional Re-
view Board, appears in 5? 46.204(c) and
46.205 respectively.
Because biomedical research is not yet
near the point of being able to maintain
for a substantial period the non-im-
planted product of in vitro fertilization,
these regulations do not address this
point. Given the state of the research, we
believe that regulations would be pre-
mature. However, the Department an-
ticipates that such a regulation will be*
prepared when the state of biomedical
science so warrants.
Activities involving fetuses in utero or
pregnant women. A number of com-
menters suggested that the rulemaking,
as proposed, would hamper research nec-
essary to meet the health needs of preg-
nant women, fetuses, and neonates. The
most frequent references were to studies
on placental transfer, the normal course
of pregnancy, and the delivery process.
Some individuals objected to the prohibi-
tion of research prior to the commence-
ment of a procedure to terminate preg-
nancy, while others objected to any con-
duct of research even during the process
of abortion.
# The Commission, in its Recommenda-
tions, separated that category of research
directed toward the pregnant woman
from that directed toward the fetus in
utero. It further distinguished between
therapeutic research and nontherapeutic
research, finding therapeutic research to
be generally acceptable and desirable,
whether directed toward the fetus or the
pregnant woman, provided certain speci-
fied preconditions are met. The Depart-
ment agrees that it is useful to distin-
guish between the fetus in utero and the
pregnant woman as the primary subject
of a research activity and also that re-
search directed at meeting the health
needs of the subject is generally accept-
able provided certain conditions are met.
The regulations therefore address these
topics in separate sections.
A. General limitations. There were no
substantive objections to the intent of re-
strictions which appeared in various
parts of the proposed rulemaking per-
taining to: (1) the necessary completion
of appropriate animal studies; or (2) the
separation of research personnel from
decisions regarding the timing or method
of terminating pregnancy or regarding
the viability of a delivered fetus. Some
commenters, and the Commission, rec-
ommended the addition of appropriate
studies on nonpregnant humans as a pre-
requisite for research activities covered
by this subpart. The Commission fur-
ther recommended that there should be
no significant changes introduced into a
delivery procedure solely in the Interests
of research. The Depaitment has incor-
porated these provisions in a section
titled "General limitations'' ( § 46.206
1
which governs all research activities cov-
ered by this subpart.
B. Activities directed toward pregnant
women as subjects. As noted above, there
was little objection from commenters on
from the Commission regarding research
directed toward the health needs of the
pregnant woman. In fact, some respond-
ents urged that care be taken not to in-
fringe the woman's right to privacy and
her access to health care. With respect to
women's rights, a number of individu ils
objected to the provision requiring con-
sent other than that of the pregnant
woman for research directed toward the
health needs of the pregnant woman,
and some objected to such consent pro-
visions even when the woman would be
participating in nontherapeutic research
activities.
• The Commission considered that the
woman's right to health care is preemi-
nent, and recommended essentially no re-*
strlctions on research directed toward
the health care of the pregnant woman,
so long as the risks to her fetus are mini-
mized as much as possible consistent with
meeting her health needs, and provided
that she is fully advised of the risks to
herself and her fetus. In addition, the
general provisions for prerequisite re-
search and for adequate review and su-
pervision of the consent process should
be met. The Department agrees.
• With respect to research directed to-
ward the pregnant woman but which is
not directed toward her health care,
there seems to be general agreement that
such research should be permitted only
if it imposes minimal or no risk to the
fetus. There is disagreement among the
commenters with respect to paternal con-
sent for this category of research. The
Department has considered with care the
various arguments with respect to con-
sent other than the pregnant woman's
for nontherapeutic research Involving
the pregnant woman, and concludes that
such consent should be obtained except
where such research involves the health
needs of the woman.
« In general, women who are victims of
rape are not appropriate subjects for
nontherapeutic research. There are some
instances, however, in which their partic-
ipation may be sought (as in studies
concerning the effects of rape.) Consent
other than hers is not necessary in such
cases.
• It should be noted in this regard that
the Commission, in a number of in-
stances, recommended that research be
permitted if the mother has consented
and the father has not objected. The
Department has concluded that Imple-
mentation of a provision for absence of
objection might present serious problems.
Since the absence of objection can best
be verified by requesting consent, the De-
partment has retained the requirement
for paternal consent when the father's
identity and whereabouts can reasonably
be ascertained, and if he is reasonably
available.
C. Activities directed towards fetuses
in utero as subjects. No comments were
received which expressed objections to
the conduct of research activities di-
rected toward the health care of the
fetus in utero. Rather, the Department
was urged not to restrict, and even to en-
courage, such research.
On the other hand, there was consid-
erable division of opinion regarding re-
search directed toward the fetus which is
not related to its health care. Concern
was expressed that the fetus might, be
used as an experimental "object," in a
manner inconsistent with Its human
genetic heritage. This is particularly true
when termination of pregnancy is a fac-
tor in the reseaich, as in protocols de-
signed to determine the effect on the
fetus of drugs administered to a pregnant
woman. Questions were raised regarding
the ethical validity of consent by a preg-
nant woman on behalf of a fetus, for its
inclusion in a research activity of no
benefit to that fetus, especially if the
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woman has already decided to terminati
her pregnancy.
•«. The Department Is sensitive to these
concerns. It has reviewed the Recom-
mendations of the Commission regarding
this category of research, and is per-
suaded that those recommendations are
sound; namely, that no research be con-
ducted or supported which fails to treat
the fetus with proper care and dignity.
In addition, the Department agrees that
a pregnant woman need not be presumed
to lack Interest in her fetus even when
she has decided to terminate her preg-
nancy; thus, she may validly be asked fc#
consent for research involving the fetus.
The Department notes that the Com-
mission was created to represent the best
judgment of the community, and to
make recommendations following an in-
tensive study of the issues. All of the
arguments which were submitted to the
Department were considered by the Com-
Ivelop new methods for enabling fetuses
to survive to the point of viability.
Activities involving the dead fetus, fe-
tal material, or the placenta. The De-
partment notes, as did the Commission,
that research involving the dead fetus
and fetal material is governed in part by
the Uniform Anatomical Gift Act which
has been adopted by 49 States, the Dis-
trict of Columbia and Puerto Rico. There
were no substantive recommendations
concerning this section, and the regu-
lation therefore differs from the pro-
posed rulemaking only with respect to
minor additions for clarification. Any
applicable State or locaL laws regard-
ing such activities are, of course, con-
trolling.
Activities to be performed outside Uk§
United States. Consistent with the Com-
mission's Recommendations, § 46.210 of
the proposed rulemaking has been de-
leted, thereby making these regulations
mission in its deliberations, and it is • applicable to all research conducted or
therefore reasonable to accept the find- I supported by the Department within the
ings of the Commission as the best pos- ( United States or abroad,
sible judgment on the matter. The ^Modification or waiver of specific re-
Department concludes that the Recom- quirements. Recognizing the difficulty
mendations of the Commission with re- of applying a specific set of regulations
spect to research involving the fetus in
utero should be adopted. These are in-
corporated In the regulations in § 46.20^
with modifications, as noted above, in
the provisions for paternal consent.
Activities directed toward fetuses ex
uiero as subjects. Although some com-
menters suggested that no research be
permitted on the fetus ex utero, others
were concerned that the proposed rule-
making was too restrictive, and would
preclude the development of technology
for sustaining premature infants. The
Commission recommended that no pro-
cedures be applied to a nonviable fetus
ex utero which would alter its duration of
life. It further recommended that if the
fetus might possibly be viable, but has
not yet been determined to be so, no
additional risk to the well-being of that
fetus should be imposed by research. It
is expected that no procedures will be
undertaken which fail to treat the fetus
with due care and dignity, or which
affront community sensibilities. Further,
It is required that if a delivered fetus is
determined to be viable, it will be treated
as a premature infant, and may be in-
cluded in research activities according to
the regulations to be proposed governing
the participation of children in research.
For the reasons stated abo* re, the De-
partment has concluded that the Recom-
mendations of the Commission regard-
ing research on the fetus ex utero should
be adopted, for the most part. These are
Incorporated in § 46.209 of the regula-
tions with modifications, as noted above,
in the provisions for paternal consent.
However, the Secretary is persuaded by
the weight of scientific evidence that re-
search performed on the nonviable fetus
ex utero has contributed substantially to
the ability of physicians to bring to via-
bility increasingly small fetuses. The Sec-
retary perceives that it is in the public
interest to continue this successful re-
search and accordingly an exception is
I made to the Recommendations of the
l^Commission to permit research to de-
to all situations that may arise In the
future, the Department has elected to
provide a mechanism for waiver or modi-
fication of specific provisions under cer-
tain circumstances. Requests from an
applicant or offeror for such a waiver or
modification must be reviewed by the
appropriate Ethical Advisory Board,
which after opportunity for public in-
put, shall advise the Secretary as to
whether or not the request should be
approved. These Boards will conform to
the operating procedures required by
the Federal Advisory Committee Act.
Activities conducted by departmental
employees. In order to make it clear that
the requirements of these regulations
(Part 46) apply to activities conducted
by its own employees, the Department
is adding subpart C titled "Activities
Conducted by Departmental Employees"
as § 46.301.
The moratorium on fetal research im-
posed on August 27, 1974, is hereby lift-
ed, but such research will be conducted
or supported by the Department only
in accordance with the following regu-
lations.
Written comments concerning the
Recommendations of the Commission
may be sent to the Office of Protection
from Research Risks, National Insti-,
tutes of Health, 9000 Rockville Pike,
Bethesda, Maryland 20014. All comments
received will be available for inspection
at the National Institutes of Health,
Room 303, Westwood Building, 5333
Westbard Avenue, Bethesda, Maryland,
-weekdays (Federal holidays excepted)
between the hours of 9 a.m. and 4; 30.
These regulations shall become effec-
tive on August 8, 1975.
Date: July 17. 1975.
Theodore Cooper.
Assistant Secretary for Health
Approved; July 29, 1975.
Caspar W. Weinberger,
Secretary.
Accordingly Part 46 of 45 CFR Sub-
title A is amended by
:
§§46.101-46.122 [ Redesignated 1
1. Designating §§ 46.1 through 46.22
as Subpart A, renumbering these as
85 46.101 through 46.122, and modifying
all references thereto accordingly.
§ 46.102 [Amended]
2. Adding the word "and" at the end
of 8 46.102(b)(2), changing the semi-
colon at the end of 8 46.102(b)(3) to
a period, and deleting 8 46.102(b) (4)
.
3. Redesignating 8 46.102(c) as §46-
102(e) and Inserting the following new
§§ 46.102(c) and 46.102(d) :
§ 46.102 Policy.
* * * * *
(c) Unless the activity is covered by
Subpart B of this Part, if it involves as
subjects women who could become preg-
nant, the Board shall also determine as
part of its review that adequate steps
will be taken in the conduct of the ac-
tivity to avoid involvement of women who
are in fact pregnant, when such activity
would involve risk to a fetus.
(d) Where the Board finds risk is in-
volved under paragraph (b) of this sec-
tion, it shall review the conduct of the
activity at timely intervals.
* * *• «
4. Adding the following new Subpail
BandC.
Subpart B—Additional Protections Pertaining to
Research, Development, and Related Activities*
Involving Fetuses, Pregnant Women, and Mu





46.204 Ethical Advisory Boards.
46.205 Additional duties of the Institutional
* Review Boards In connection 'with
activities Involving fetuses, preg-
nant women, or human in vitro
fertilization.
General limitations.
Activities directed toward pregnai.l
women as subjects.
Activities directed tow.ird fetuses in
utero as subjects.
Activities directed toward fetuses ei
utero, including nonviable fetuse:..
as subjects.
Activities involving the dead fetus,
fetal material, or the placenta.










46.301 Activities conducted by Department
employees.
Authority: 5 U.S.C. 301.
Subpart B—Additional Protections Pertain-
ing to Research, Development, and Re-
lated Activities Involving Fetuses, Preg-
nant Women, and Human In Vitro Fer-
tilization
§ 46.201 Applicability.
(a) The regulations in this subpart are
applicable to all Department of Health,
Education, and Welfare grants and con-
tracts supporting research, development,
and related activities involving: (1) The
fetus, (2) pregnant women, and (3) hu-
man in vitro fertilization.
(b) Nothing in this subpart shall be
construed as indicating that compliance
FEDERAL REGISTER, VOL 40, NO 154—FRIDAY, AUGUST 8, 1975
RULES AND REGULATIONS :\:):,2 (.)
with the procedure? set forth herein will
)n any way render inapplicable pertinent
State or local laws bearing upon activi-
ties covered by this subpart.
(c) The requirements of this subpart
are in addition to those imposed under
the other subparts of this part.
§ 16.202 Purpose.
It is the purpose of this subpart to
provide additional safeguards in review-
ing activities to which this subpart is
applicable to assure that they conform
to appropriate ethical standards and re-
late to important societal needs.
g 16.203 Definitions.
As used in this subDart:
ta) "Secretary" means the Secretary
of Health, Education, and Welfare and
any other officer or employee of the De-
partment of Health, Education, and
Welfare to whom authority has been
delegated.
(b> "Pregnancy" encompasses the pe-
riod of time from confirmation of im-
alantation until expulsion or extraction
>f the fetus.
(c) "Fetus" means the product of con-
:eption from the time of implantation
antil a determination is made, following
expulsion or extraction of the fetus, that
t is viable.
(d) "Viable" as it pertains to the fetus
neans being able, after either spontane-
ous or induced delivery, to survive (given
;he benefit of available medical therapy)
» the point of independently maintain-
ng heart beat and respiration. The Sec-
retary may from time to time, taking
nto account medical advances, publish
n the Federal Register guidelines to as-
sist in determining whether a fetus is
liable for purposes of this subpart. If a
"etus is viable after delivery, it is a pre-
mature infant.
(e) "Nonviable fetus" means a fetus
ix utero which, although living, is not
liable.
(f ) "Dead fetus" means a fetus ex utero
vhich exhibits neither heartbeat, spon-
taneous respiratory activity, spontaneous
novement of voluntary muscles, nor pul-
sation of the umbilical cord (if still
attached)
.
(g) "In vitro fertilization" means any
iertilization of human ova which occurs
wtside the body of a female, either
through admixture of donor human
sperm and ova or by any other means.
§ 46.204 Ethical Advisory Boards.
(a) Two Ethical Advisory Boards shall
be established by the Secretary. Members
of these Boards shall be so selected that
the Boards will be competent to deal with
medical, legal, social, ethical, and related
Issues and may include, for example, re-
search scientists, physicians, psycholo-
gists, sociologists, educators, lawyers, and
ethicists, as well as representatives of
the general public. No board member
may be a regular, full-time employee of
the Federal Government.
(b) One Board shall be advisory to the
Public Health Service and its compo-
nents. One Board shall be advisory to all
other agencies and components within
the Department of Health. Education,
and Welfare.
(c) At the reauest of the Secretary, the
appropriate Ethical Advisory Board shall
render advice consistent with the policies
and requirements of this Part as to eth-
ical issues, involving activities covered by
this subpart, raised by individual appli-
cations or proposals. In addition, upon
request by the Secretary, the appropriate
Board shall render advice as to classes
of applications or proposals and general
policies, guidelines, and procedures.
(d) A Board may establish, with the
approval of the Secretary, classes of ap-
plications or proposals which: (1) Must
be submitted to the Board, or (2) need
not be submitted to the Board. Where the
Board so establishes a class of applica-
tions or proposals which must be sub-
mitted, no application or proposal within
the class may be funded by the Depart-
ment or any component thereof until the
application or proposal has been reviewed
by the Board and the Board has rendered
advice as to its acceptability from an
ethical standpoint.
(e) No application or proposal involv-
ing human in vitro fertilization may be
funded by the Department or any com-
ponent thereof until the application or
proposal has been reviewed by the Eth-
ical Advisory Board and the Board has
rendered advice as to its acceptability
from an ethical standpoint.
g 16.203 Additional duties of the Institu-
tional Review Boards in conneetion
with activities involving fetuses, preg-
nant women, or human in vitro fer-
tilization.
* i a) In addition to the responsibilities
prescribed for Institutional Review
Boards under Subpart A of this part,
the applicant's or offeror's Board shall,
with respect to activities covered by this
subpart, carry out the following addi-
tional duties:
(1) Determine that all aspects of the
activity meet the requirements of this
subpart;
(2) Determine that adequate consid-
eration has been given to the manner in
which potential subjects will be selected,
and adequate provision has been made
by the applicant or offeror for monitoring
the actual informed consent process (e.g.,
through such mechanisms, when appro-
priate, as participation by the Institu-
tional Review Board or subject advocates
in: (i) Overseeing the actual process by
which individual consents required by
this subpart are secured either by ap-
proving induction of each individual into
the activity or verifying, perhaps through
sampling, that approved procedures for
Induction of individuals into the activity
are being followed, and <ii) monitoring
the progress of the activity and interven-
ing as necessary through such steps as
visits to the activity site and continuing
evaluation to determine if any unantici-
pated risks have arisen)
;
(3) Carry out such other responsibili-
ties as may be assigned by the Secretary.
(b) No award may be issued until the
applicant or offeror has certified to the
Secretary that the Institutional Review
Board has made the determinations re-
quired under paragraph (a) of this sec-
tion and the Secretary has approved
these determinations, as provided m
§ 46.115 of Subpart A of this part.
(c) Applicants or offerors seeking sup-
port for activities covered by this sub-
part must provide for the designation of
an Institutional Review Board, subject
to approval by the Secretary, where no
such Board has been established u.ider
Subpart A of this part.
§ 46.206 General limitations.
ia) No activity to which this subpart
is applicable may be undertaken unles;
(1) Appropriate studies on animals
and nonpregnant individuals have bPc n
completed;
(2) Except where the purpose of uie
activity is to meet the health needs of the
particular fetus, the risk to the fetus is
minimal and, in all cases, is the least
possible risk for achieving the objectives
of the activity;
(3) Individuals engaged in the activ-
ity will have no part in: ri> Any deci-
sions as to the timing, method, and pro-
cedures used to terminate the pregnancy,
and (ii) determining the viability of the
fetus at the termination of the preg-
nancy; and
(4) No procedural changes which may
cause greater than minimal risk to the
fetus or the pregnant woman will be in-
troduced into the procedure for termi-
nating the pregnancy solely in the inter-
est of the activity.
<b) No inducements, monetary or
otherwise, may be offered to terminate
pregnancy for purposes of the activity.
§ 46.207 Activities directed toward preg-
nant women as subjects.
(a) No pregnant woman may be in-
volved as a subject In an activity cov-
ered by this subpart unless: (1) The
purpose of the activity is to meet the
health needs of the mother and the fetus
will be placed at risk only to the mini-
mum extent necessary to meet such
needs, or (2) the risk to the fetus is mini-
mal.
(b) An activity permitted under para-
graph (a) of this section may be con-
ducted only if the mother and father are
legally competent and have given their
informed consent after having been fully
informed regarding possible impact on
the fetus, except that the father's in-
formed consent need not be secured if:
(1) The purpose of the activity is to
meet the health needs of the mother; (2i
his identity or whereabouts cannot rea-
sonably be ascertained ; (3) he is not rea-
sonably available; or (4) the pregnancy
resulted from rape.
§46.208 Activities directed toward IV-
tuses iii utero as subjects.
ia> No fetus in utero may be involved
as a subject in any activity covered by
this subpart unless: (1) The purpose of
the activity is to meet the health needs
of the particular fetus and the fetus will
be placed at risk only to the minimum ex-
tent necessary to meet such needs, or (2i
the risk to the fetus imposed by the re-
FEDERAL REGISTER, VOt. 40, NO. 154
—
FRIDAY, AUGUST 8, 1975
r,no RULES AND REGULATIONS
search is minimal and the purpose of the
activity is the development of import-
ant biomedical knowledge which cannot
be obtained by other means.
b > An activity permitted under para-
graph (a i of this section may be con-
ducted only if the mother and father are
legally competent and have given their
i'tformed consent, except that the
father's consent need not be secured If:
< 1 1 His identity or whereabouts cannot
ieasonably be ascertained, (2) he is not
reasonably available, or (3) the preg-
nanes resulted from rape.
$ Hi.204> Activities directed tovtxrtl fc-
i,i*f« cv litem, including nonviable
i» lu&e.s, as subjects.
a > No fetus ex utero may be involved
as a subject in an activity covered by this
subpart until it has been ascertained
whether the particular fetus is viable,
unless: (1) There will be no added risk
to the fetus resulting from the activity,
and (2) the purpose of the activity is the
development of important biomedical
knowledge which cannot be obtained by
other means.
<b) No nonviable fetus may be in-
volved as a subject in an activity covered
by this subpart unless: (1) Vital func-
tions of the fetus will not be artificially
maintained except where the purpose of
the activity is to develop new methods
for enabling fetuses to survive to the
point of viability, (2) experimental ac-
tivities which of themselves would ter-
minate the heartbeat or respiration of
the fetus will not be employed, and (3>
the purpose of the activity is the develop-
ment of important biomedical knowledge
u hich cannot be obtained by other means.
< c i In the event the fetus ex utero is
found to be viable, It may be included
as a subject in the activity only to the
extent permitted by and in accordance
with the requirements of other subparts
of this part.
<d> An activity permitted under para-
graph (a) or (b) of this section may be
conducted only if the mother and father
are legally competent and have given
their informed consent, except that the
father's Informed consent need not be
secured If: (1) hla Identity or where-
abouts cannot reasonably be ascertained,
1 2 1 he Is not reasonably available, or < 3
1
the pregnancy resulted from rape.
§ 46.210 Activities involving the dead
fetus, fetal material, or the placenta.
Activities involving the dead fetus,
mascerated fetal material, or cells, tis-
sue, or organs excised from a dead fetus
shall be conducted only In accordance
with any applicable State or local laws
regarding such activities.
§46.211 Modification or waiver of spe-
cific requirements.
Upon the request of an applicant or
offeror (with the approval of its Institu-
tional Review Board) , the Secretary may
modify or waive specific requirements of
this subpart, with the approval of the
Ethical Advisory Board after such oppor-
tunity for public comment as the Ethical
Advisory Board considers appropriate in
the particular instance. In making such
decisions, the Secretary will consider
whether the risks to the subject are so
outweighed by the sum of the benefit to
the subject and the importance of the
knowledge to be gained as to warrant
such modification or waiver and that
such benefits cannot be gained except
through a modification or waiver. Any
such modifications or waivers will be pub-
lished as notices in the Federal Register.
Subpart C—General Provisions
§ 16.301 Activities conducted by Depart-
ment employees.
The regulations of this part are appli-
cable as well to all research, development,
and related activities conducted by em-
ployees of the Department of Health,
Education, and Welfare, except that each
Principal Operating Component head
may adopt such non-substantive proce-l
dural modifications as may be appropri-J
ate from an administrative standpoint.
The National Commission for the Pro-
tection of Human Subjects of Bio-
medical and Behavioral Research




Kenneth John Ryan, MD, Chairman, Chief
of Staff, Boston Hospital for Women.
Joseph V. Brady, Ph.D., Professor of Behav-
ioral Biology, Johns Hopkins University.
Robert E. Cooke, M.D., Vice Chancellor for
Health Services, University of Wisconsin.
Dorothy I. Height. President, National Coun-
• cU of Negro Women, Inc.
Albert R. Jonsen, S.J., Ph.D.. Adjunct Associ-
ate Professor of Bloethlcs, University of
California at San Francisco.
Patricia King, J.D., Professor of Law, George-
town University Law Center.
Karen A. Lebacqz, Ph.D., Assistant Professor
of Christian Ethics, Pacific School of Re-
ligion.
David W. Louisell, J.D., Professor of Law,
University of California at Berkeley.
Donald W. Seldln, M.D., Professor and Chair-
man, Department of Internal Medicine,
University of Texas at Dallas.
Eliot Stellar, Ph.D., Provost of the University
and Professor of Physiological Psychology,
University of Pennsylvania.
Robert H. Turtle, LL.B., Attorney. VomBaur,
Coburn, Simmons & Turtle, Washington,
DC.
COMMISSION STAFF
Charles U. Lowe, M.D., Executive Director.
Michael S. Yesley, J.D., Staff Director.
Duane Alexander, M.D., Pediatrics.
Edward Dixon, J.D., Attorney.
Bradford Gray, Ph. D., Sociology.
Miriam Kelty, Ph. D., Psychology.
Robert Levlne, M.D., Internal Medicine.
Barbara Mlshkln, M.A., Philosophy and
Psychology.
R. Anne Ballard, Public Information Officer.















II. The Nature and Extent of Research In-
volving the Fetus and the Purposes for
Which Such Research Has Been
Undertaken.
III. Alternative Means for Achieving the
Purposes for Which Research Involving
Living Fetuses Has Been Unde/ taken.
IV. Legal Issues.
V. Ethical Issues.
VI. Views Presented at Public Hearing
VII. Fetal Viability and Death.
VIII. Deliberations and Conclusions
IX. Recommendations.
I. The Mandate
The National Research Act 'Pub L
93-348i established the National Com-
mission for the Protection of Humau
Subjects of Biomedical and Behavioral
Research and gave the Commission a
mandate to investigate and study re-
search involving the living fetus, fnd to
recommend whether and under what
circumstances such research should be
conducted or supported by the De-
partment of Health. Education, and
Welfare. A deadline of four months
after the members of the Commission
took office was imposed for the Commis-
sion to conduct its study and make
recommendations to the Secretary,
DHEW. The priority assigned by Con-
gress to research involving the fetus in-
dicates the concern that unconscionable
acts involving the fetus may have been
performed in the name of scientific in-
quiry, with only proxy consent on behalf
of the fetus.
The members of the Commission
determined at the outset to undertake
a careful study of the nature and extent
of research on the fetus, the range of
views on the ethical acceptability of
such research, and the legal issues in-
volved, prior to formulating their recom-
mendations. To this end, the Commis-
sion has accumulated an extensive body
of Information, held public hearings,
questioned a panel of distinguished
ethicists, and conducted lengthy delib-
erations. In the course of these activities,
the Commission has given close
scrutiny to many important questions
that surround research on the fetus, for
example: What are the purposes of re-
search on the fetus? What procedures
have been employed in such research
Are there alternatives to such research?
Can appropriate consent to such re-
search be obtained by proxy? Under
what conditions may research be done
on a fetus that is to be aborted, or a
nonviable delivered fetus? What review
of proposed research should be required?
In the remainder of Section I, the
background and activities of the Com-
mission are summarized, and the defini-
tions used In this report are set forth.
Reports, papers and testimony that were
prepared for or presented to the Com-
mission are summarized In Sections II
FEDERAL REGISTER, VOL. 40, NO. 154—FRIDAY. AUGUST 8, 1975
APPENDIX E
REVIEW OF THE USE OF HUMAN SUBJECTS: INSTRUCTIONS
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Appendix E . Review of the Use of Human Subjects: Instructions
for Investigators
Who needs to seek review ?
Any individual who is responsible for an activity involving
human subjects conducted at or sponsored by the University of Illinois -
Urbana-Champaign
.
What kinds of activity require review?
Any activity involving human subjects , i.e., human beings whose
physical, emotional or behavioral condition, responses, tissues or fluids
are investigated for any purpose other than for the sole purpose of benefit-
ting the subject as an individual. The use of interviews, tests, observa-
tions and inquiries designed to elicit non-public information about indivi-
duals or groups must be reviewed. Routine course development, including
evaluation of the effectiveness of such development, in courses sponsored
by UIUC do not need review. Nor do non-intervening observation of public
behavior, secondary use of data if the subjects are not identifiable, and
use of publicly available data whether or not the subjects are identifiable.
Research projects, demonstration activities, pilot projects,
student dissertation projects, independent study projects, course pro-
jects must be reviewed if they involve human subjects.
What is meant by the terms subject, research, " a t risk", informed consent?
See Part II, pages 5-13, of The Use of Human Subjects in Research
at the University of Illinois - irbana-Champaign (copies available in depart-
mental offices or from the Executive Secretary of the Institutional Review
Board.
)
What is the purpose of the review?
The purpose of the review is to obtain an independent deter-
mination of whether the human subjects will be placed at risk , and if
risk i_s involved, that
a) any risks to the subject are so outweighed by the sum of
the benefit to the subject and importance of the knowledge
to be gained as to warrant a decision to allow the project
to be undertaken
;
b) the welfare of any such subjects will be adequately protected;
and
c) legally effective informed consent will be obtained by adequate
and appropriate methods.
When must an activity involving human subjects be reviewed ?
Prior to initiation of activity, prior to implementation of
any changes in procedures involving human subjects, and at least annually
during the lifetime of the project. If the project is being proposed for
external funding, review should take place prior to submission of proposal
to funding agency.
Who will perform the review ?
The identity of the reviewers will depend upon the nature
of the activity as follows:
Source of funding Nature of Activity Reviewer








Department does not have
IRB approved guidelines IRB
Externally funded IRB
-3-
What must be submitted to reviewers ?
1. Form IRB-1, "Information for Review of Activity involving
Human Subjects"
This form must be submitted for all activities to be
reviewed by the 1KB. Its use in departmental review
of non-externally funded activities falling within
1KB approved departmental guidelines is optional.
Check with department executive officer.
2. Description of project, its objectives and significance
If the project is being proposed to an external
funding agency, submit a copy of the proposal.
3. Description of method to be used for obtaining subjects
and for assuring that their participation is voluntary.
In the selection of potential subjects, prior professional
relationships must be respected. If the study involves patients
or clients, then the personal physician or other professional
involved must first determine that the patient or client is
willing to discuss the study before the investigator can approach
the potential subject.
If physicians or agencies merely provide the investigator with
the names of those patients or clients with characteristics
that make them eligible as subjects in the study, they are
violating their confidential relationships. Investigators should
neither request nor accept the names unless they are assured that
the patients or clients have agreed to be approached.
k. Description of how subjects will be used, the possible
risks to the subject, the potential benefits to the subject
and/or to others.
The material submitted should be brief, concise, but complete.
For example, if human blood will be used, identify the donors,
how they will be asked to participate, amount of blood to
be taken, how it will be taken, by whom, (indicate
credentials) how frequently, If drugs are to be administered,
indicate identity of drug, whether or not it is FDA certified,
dosage, by whom it will be administered, period of admini-
stration, anticipated effects.
If subjects will be interviewed or will be asked to
complete questionnaires or take tests, indicate the nature
of questions or test material, the degree of confidentiality
needed and how it is to be assured.
If any initial deception is involved to avoid invalidation
or biasing of the investigation, indicate what information
will be withheld, why incomplete disclosure is justified,
and describe the debriefing procedure to be used.
If subjects are to receive payment or other incentives for
participation, describe such incentives. Note that payment
to subjects is considered to be income by the Internal Revenue
Service, and must be reported as such.
5. Description of the method to be used for securing legally
effective informed consent of subjects who will be placed
at risk .
Note that the signature of a parent or legal guardian
is necessary to obtain legally effective informed consent
of a subject who is a minor or who is other wise considered
legally incompetent.
Copies of sample consent forms to be used and any written
or oral explanation to be given to subjects must be submitted
to the IRB for review.
Note that DHEW has specific requirements regarding the
obtaining and documenting of informed consent. See
Appendix D, Sections 46.9 and 46.10. Sample consent forms
which satisfy these regulations are provided in Appendix A.
6. Description of provisions for safeguarding the rights and
welfare of the human subjects to be involved, including
the provisions for assuring confidentiality of data and any
provision for medical care or supervision.
How will project director find out result of review ?
Results of reviews conducted by IRB will be provided to
project director by letter from the Executive Secretary of the IRB.
Results of reviews conducted by department executive officers
or their designee will be reported in accordance with departmental
practice. Check with the department executive officer for further
information.
How can a project director obtain information or advice and counsel
regarding the use of human subjects ?
The investigator may contact the Executive Secretary of the
Institutional Review Board who will either provide the information
requested or arrange for the investigator to discuss the matter with
one or more members of the Institutional Review Board.
Are there special requirements for review of the use of subjects if
access to the subjects is gained through cooperating institutions not
under the control of the university ?
There may be. If the subjects are not at risk, no special
documentation is required, but investigators gaining access to
subjects in another institution should always assure that the
authorized official of the institution is informed of the study.
If the subjects are at risk, the material submitted for IRB
review of the project must include the following information.
Status of Subjects: (~~J Wards £J Residents f~j Employees
f~l Patients [J Students [~J Other (explain)
Number of Subjects: Age Range of Subjects:










Who is responsible for informed consent documents ?
The investigator is responsible for obtaining and storing signed
consent documents. These documents should be handled and stored
appropriately to protect the identity of the subject. They must be
available for IRB inspection upon request. If the investigator leaves
the university, the signed consent forms must be turned over to the IRB
and must be retained at the University so that it can fulfill its
administrative responsibilities.
How long must records on the use of human subjects be retained ?
If the project is externally supported, the terms of the grant
or contract usually indicate how long records must be retained.
Usually a period of five years beyond expiration of the support
agreement is sufficient for compliance with the terms of the agree-
ment. Since the Illinois statute of limitations and discovery also
apply, it is advisable for the investigator to consult the univer-
sity's legal counsel before destroying such records. Consent docu-
ments and other important records relating to the use of minors who
were placed at risk should be retained until at least two years
after the minor reaches majority.
For projects which are not externally funded, the IRB recommends
retention of documents for five years beyond termination of the project,
unless the nature of the project indicates that a longer time would be
advisable. Again the Illinois statute of limitations and discovery
apply so that advice from legal counsel is appropriate before records
are destroyed.
How should emergencies involving human subjects be handled ?
The university maintains McKinley Health Center, which includes
a hospital having 58 beds, the usual hospital facilities, and a staff
of physicians. This facility is available for emergencies that may
arise in course of UIUC activities involving human subjects. Arrange-
ments may be made for physicians from McKinley Health Center or from
local hospitals to monitor work involving human subjects when the
Institutional Review Board finds the element of risk to warrant
supervision by medical personnel.
What are the subject's privileges ?
If a subject or prospective subject wishes to review the UIUC
policies and procedures, he/she may request a copy from the depart-
ment executive officer or the Executive Secretary of the Institutional
Review Board, or may review it in the Reference Room of the Univer-
sity Library. Copies of the UIUC Assurance filed with DHEW are
available in the Office of the Executive Secretary of the Institutional
Review Board. One copy is on file in the University Library Reference
Room.
If a subject wishes to voice complaints or concerns regarding
his/her participation in a project, he/she should take the matter
to the executive officer* of the department in which the activity
is supervised. The subject may, if not satisfied with the results
of that process, refer his/her concerns to the Executive Secretary
of the Institutional Review Board, who will arrange for the matter
to be considered by the Institutional Review Board.
it executive officers are responsible for notifying the Institutional
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